Viewport Size Code:
Login | Create New Account
picture

  MENU

About | Classical Genetics | Timelines | What's New | What's Hot

About | Classical Genetics | Timelines | What's New | What's Hot

icon

Bibliography Options Menu

icon
QUERY RUN:
HITS:
PAGE OPTIONS:
Hide Abstracts   |   Hide Additional Links
NOTE:
Long bibliographies are displayed in blocks of 100 citations at a time. At the end of each block there is an option to load the next block.

Bibliography on: CRISPR-Cas

The Electronic Scholarly Publishing Project: Providing world-wide, free access to classic scientific papers and other scholarly materials, since 1993.

More About:  ESP | OUR CONTENT | THIS WEBSITE | WHAT'S NEW | WHAT'S HOT

ESP: PubMed Auto Bibliography 18 Nov 2026 at 01:45 Created: 

CRISPR-Cas

Clustered regularly interspaced short palindromic repeats (CRISPR, pronounced crisper) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to foreign DNA (e.g a virus or plasmid). The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea. By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015.

Created with PubMed® Query: ( "CRISPR.CAS" OR "crispr/cas" ) NOT pmcbook NOT ispreviousversion

Citations The Papers (from PubMed®)

-->

RevDate: 2026-11-17
CmpDate: 2026-11-17

Sang X, Zhang H, Zhang Y, et al (2026)

Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers.

Parasites & vectors, 19(1):.

Toxoplasma gondii is a protozoan parasite that infects nearly one third of the world's population and endangers the health of immunocompromised people, pregnant women, and livestock. There are no existing drugs able to treat the infection and prevent tissue cysts from developing. Therefore, the creation of a safe vaccine should be considered as a matter of great importance. While many of the vaccines have not proven successful in the past, recently created live-attenuated vaccines (LAVs) using CRISPR-Cas9 gene editing technology were able to outperform the previous ones. The current review aims to highlight the recent progress in genetically engineered LAVs against T. gondii. In particular, the knockout strains affecting metabolic genes (ompdc, uprt, and adsl), virulence genes (rop18), and host-parasite interactions (gra5, gra72, had2a, and cdpk3) will be mentioned. LAVs described above demonstrate high attenuating effects and ability to protect mice by inducing immunity on the basis of specific IgG (IgG2a), IFN-γ, IL-12, and CD4[+], CD8[+] T cells. Furthermore, vaccination provides protection from a lethal infection caused by types I, II, and Chinese 1 strains of T. gondii as well as preventing development of tissue cysts in chronic infection. RHΔompdcΔuprt is an example of an LAV that can be used to reduce oocyst shedding in cats and promote the One Health concept. In general terms, genetically engineered LAVs can effectively deal with toxoplasmosis infection with better attenuation immunogenicity balance than other vaccines. Nonetheless, several problems need consideration.

RevDate: 2026-11-17
CmpDate: 2026-11-17

Golubeva J, Mikhailov A, Shepelev N, et al (2026)

Genome-wide CRISPR-Cas9-based screening revealed the role of ubiquitin ligase TRIM25 in ribosome degradation via ribophagy.

Autophagy, 22(12):3599-3614.

Ribophagy is a crucial mechanism that maintains ribosome homeostasis in the cell by directing nonfunctional ribosomes to degradation via macroautophagy/autophagy. Impaired ribophagy may lead to ribosome quality control disorders and may consequently be associated with various diseases known as ribosomopathies. This topic has been actively studied over the past decade, but the complete mechanism of ribophagy is not fully understood. To study the mechanism of ribophagy, we performed a genome-wide CRISPR-Cas9-based screening using a fluorescent ribophagy reporter, which is a cell line with ribosomes carrying RPL29 fused with mCherry and GFP fluorescent proteins. Using the genome-wide Brunello library of guide RNAs, we identified the most promising targets for further study, including the ubiquitin ligase TRIM25, for which we have shown specific binding to the ribosome during ribophagy induction, leading to ubiquitination of the ribosome on the nascent peptide chain and degradation of the whole ribosome. Our findings also demonstrated that poly(I:C) treatment, which mimics viral infection, activates ribophagy in a TRIM25-dependent manner, suggesting the ribophagy pathway could be an antiviral defense mechanism. Taken together, we discovered a novel regulator of ribophagy, TRIM25, which provides new insights into the regulation of selective autophagy in the context of ribosomopathies.Abbreviations: CHX: cycloheximide; FACS: fluorescence-activated cell sorting; GFP: green fluorescent protein; MAGeCK: model-based Analysis of Genome-wide CRISPR-Cas9 Knockout; MOI: multiplicity of infection; poly(I:C): polyinosinic:polycytidylic acid; RFP: red fluorescent protein.

RevDate: 2026-11-16
CmpDate: 2026-11-16

Lampe GD, King RT, SH Sternberg (2026)

Programmable enzymes for targeted gene insertion.

Nature reviews. Genetics, 27(12):920-934.

Genome editing technologies have advanced from nuclease-based reagents that generate programmed DNA double-strand breaks, which can cause deleterious effects, to next-generation reagents that perform controlled DNA modification through double-strand break-independent mechanisms, such as base editing and prime editing. Although these approaches enable precise small-scale sequence changes, methods for programmable insertion of large DNA cargos have been limited. The ability to write entire genes or large regions into the genome could transform the treatment of genetically heterogeneous disorders, for which numerous pathogenic variants underlie a common disease and mutation-specific editing strategies are impractical. Recent advances in computational genome mining have accelerated the discovery of naturally occurring enzymes with novel biochemical and functional properties, including recombinases and transposases capable of large-scale modifications. Moreover, directed evolution, rational engineering and expanded homologue discovery are enabling the repurposing and optimization of these systems for genome engineering. Here we review recent technology development efforts that harness diverse enzymes for kilobase-scale genome engineering, with a particular focus on CRISPR-associated transposase systems.

RevDate: 2026-11-17
CmpDate: 2026-11-17

Yu S, Chen Z, Zhang J, et al (2026)

LwaCas13a protein- and crRNA-enabled RPA-CRISPR/Cas13a platform for rapid visual differentiation of goose parvovirus and novel goose parvovirus.

International journal of biological macromolecules, 383(Pt 2):154658.

Waterfowl parvoviruses, including goose parvovirus and novel goose parvovirus, are highly transmissible pathogens that pose serious threats to flock health and the poultry industry. In this paper, we report a macromolecule-enabled recombinase polymerase amplification (RPA)-CRISPR/Cas13a platform for the rapid, sensitive, and field-deployable visual detection of these viruses by, targeting VP3. Guided by crRNA, LwaCas13a specifically recognizes complementary target RNA and is activated to exert non-specific collateral cleavage activity, efficiently degrading nearby single-stranded RNAs. Species-conserved VP3 fragments with stable interspecies differences were used to design RPA primers and crRNAs, and reaction conditions were systematically optimized. This dual-mode system integrates real-time fluorescence with lateral flow test strips detection, achieving fluorescence detection limits of 1 × 10[0] copies/μL and lateral flow test strips detection limits of 1 × 10[1] copies/μL for goose parvovirus and 1 × 10[2]copies/μL for novel goose parvovirus, with no cross-reactivity with common avian pathogens. Clinical validation demonstrated high concordance with qPCR and superior sensitivity to conventional PCR. Overall, this macromolecule-driven RPA-CRISPR/Cas13a assay offers a robust, rapid, and accurate tool for the on-site differential diagnosis of waterfowl parvoviruses, enabling timely surveillance and disease control.

RevDate: 2026-11-17
CmpDate: 2026-11-17

Wang Y, Liang L, Huo D, et al (2026)

CRISPR Nanomachinery-Sensitized Nanocatalytic Tumor Ferroptosis in Triple-Negative Breast Cancer.

Advanced materials (Deerfield Beach, Fla.), 38(64):.

The luminal androgen receptor (LAR) subtype of triple-negative breast cancer (TNBC) represents a formidable therapeutic challenge, necessitating sophisticated strategies that exploit unique tumor vulnerabilities. In the present work, we introduce a biomimetic nanotherapeutic that integrates single-atom iron nanocatalysts (FeSA) co-loaded with a CRISPR-Cas9 plasmid targeting Glutathione Peroxidase 4 (Gpx4), the key regulator of ferroptosis, and is camouflaged with a homologous cancer cell membrane to ensure precise tumor tropism and excellent biocompatibility. In an orthotopic LAR-TNBC model, the nanotherapeutic achieved ∼98% tumor regression and markedly extended survival. Comprehensive mechanistic analyses confirmed efficient on-target Gpx4 disruption, which synergistically amplified the FeSA-catalyzed ferroptotic cascade. Unbiased transcriptomic profiling further revealed extensive reprogramming of the tumor molecular landscape, resulting in significant cancer cell ferroptosis by DNA damage response and p53 signaling pathway activation. This work establishes a highly synergistic and targeted approach, presenting a potent therapeutic modality for aggressive and chemoresistant malignancies.

RevDate: 2026-11-17
CmpDate: 2026-11-17

Das P, Samoi TB, B Maji (2026)

Chemically composed Cas9 (ChemComCas9) for spatio-temporal regulation and precision genome engineering applications.

Chemical communications (Cambridge, England), 62(90):23212-23228.

Chemically composed Cas9 (ChemComCas9) has emerged as a highly versatile CRISPR enzyme, offering tunable, on-demand, and targeted control over genome engineering functions. Despite its programmable, sequence-specific activity, uncontrolled or prolonged exposure to Cas9 can lead to severe genotoxicity, restricting its enormous clinical potential. To circumvent its non-specific and uncontrolled activities, Cas9 has been chemically modified for spatio-temporal and precision control. For developing such ChemComCas9, the WT Cas9 has been chemically modified using either its surface-exposed natural cysteine or by the installation of additional cysteine residues, or an unnatural amino acid has been incorporated for chemical modification. Such strategies include the incorporation of peptides, polymers, antibodies, stimuli-responsive moieties, and biorthogonal conjugation techniques that allow external control over Cas9 activation, localization, and activity. In addition, various short peptides have been either genetically fused or chemically conjugated for spatiotemporal regulation and probing. These approaches enable conditional activation of Cas9 in response to light, small molecules, or intracellular triggers, thereby minimizing off-target effects and increasing editing efficiency. In this review, we discuss a systematic evolution of chemically composed Cas9 (ChemComCas9) for precision genome engineering and gene therapy applications.

RevDate: 2026-11-16
CmpDate: 2026-11-16

Zhou X, Chen Y, Li C, et al (2026)

Rewriting wheat karyotypes through centromere-targeted chromosome engineering.

Nature plants, 12(11):2219-2233.

Engineering karyotypes could expand the genetic and breeding potential of crops, but restructuring gigabase-scale polyploid genomes remains challenging. Here we develop centromere editing-mediated chromosomal variation, a strategy using CRISPR-Cas9 to target abundant centromeric retrotransposons in hexaploid wheat. Centromere editing-mediated chromosomal variation efficiently induces simultaneous chromosome cleavage across the genome, generating diverse karyotypic variants and reconfiguring up to 11 chromosomes in one generation. Notably, it produces widespread reciprocal translocations, with one line carrying six events involving seven chromosomes. Newly formed translocation chromosomes undergo centromere remodelling, enabling their relatively stable maintenance and heritable transmission. Moreover, balanced translocations impose minimal transcriptional perturbation and maintaining normal growth. These results establish centromeres as effective sites for chromosome engineering breeding and provide a scalable framework for karyotype redesign in polyploid crops.

RevDate: 2026-11-17
CmpDate: 2026-11-17

Johansen KH, Ramanathan K, Rodriguez-Pardo C, et al (2026)

Antigen scaffolds drive preferential expansion of functional genetically engineered CAR and TCR T cells.

Cell reports. Medicine, 7(11):103128.

T cells engineered to express recombinant T cell receptors (TCRs) or chimeric antigen receptors (CARs) can induce durable clinical responses in solid and hematological malignancies. However, manufacturing is resource intensive and often yields highly differentiated, exhausted T cell products. To address this, we developed an antigen-scaffold (Ag-scaffold) technology that presents cognate antigen alongside stimulatory cytokines to preferentially expand genetically engineered T cells. We expanded CRISPR-Cas9- and lentivirally engineered TCR T cells with peptide MHC (pMHC)-presenting Ag-scaffolds and anti-CD19 CAR T cells with CD19-presenting Ag-scaffolds. By applying cognate pMHC Ag-scaffolds, we achieved on average 69% (±22%) antigen-specific T cells after 14 days of culture with a cytotoxic, proliferative profile. Ag-scaffold expansion enhanced initial TCR and CAR cytotoxicity; repeated rechallenges showed sustained control. In vivo, Ag-scaffold-expanded CRISPR-Cas9-engineered NY-ESO-1-specific TCR T cells and anti-CD19 CAR T cells also showed improved tumor control in lymphoma and solid tumor xenograft models compared to cells expanded with IL2/7/15.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Kaur N, Langley J, P Billon (2027)

Prime Editing-Mediated Genome Modification in Saccharomyces cerevisiae.

Methods in molecular biology (Clifton, N.J.), 3099:253-272.

Prime editing is a highly versatile genome editing technology that enables precise genetic modifications in eukaryotes. Here, we present a detailed step-by-step protocol for conducting prime editing in Saccharomyces cerevisiae. In particular, we describe the design of prime editing guide RNAs (pegRNAs), yeast transformation with prime editor and pegRNA plasmids, and controlled expression through galactose induction. We demonstrate the protocol by targeting the CAN1 gene and achieving editing efficiencies of 22% and 55% with two different pegRNAs. We provide protocols for genomic DNA extraction, PCR amplification, and editing quantification using both Sanger and next-generation sequencing. Given the important role of yeast in both basic research and biotechnology applications, this protocol provides valuable tools for studying gene function and precise engineering of yeast strains.

RevDate: 2026-11-12
CmpDate: 2026-11-12

Liu T, Liu K, Hou Y, et al (2026)

CRISPR screening-informed liver cancer stratification identifies ciclesonide as a novel adjuvant drug to alleviate sorafenib resistance.

BMC cancer, 26(1):.

Sorafenib remains a standard therapy for hepatocellular carcinoma (HCC), but intratumor heterogeneity and drug resistance limit its efficacy. To identify resistance-associated genes, we performed a CRISPR activation screen and integrated results with TCGA and GTEx data. Using univariate Cox and LASSO regression, we constructed a five-gene (AKR1B15, BMF, GBA, GINS2, SMC2) sorafenib sensitivity-related prognostic signature. In the TCGA-LIHC training cohort (n = 371), patients with high-risk scores showed significantly worse overall survival and reduced sorafenib sensitivity, which was validated in the ICGC-US cohort. High risk scores also correlated with adverse clinicopathological features. Drug perturbation Gene Set Enrichment Analysis (dpGSEA) identified ciclesonide as a potential sensitizer to sorafenib. Cell viability assays and a subcutaneous xenograft model confirmed that ciclesonide enhanced the antitumor efficacy of sorafenib. RNA sequencing further suggested that this effect may be mediated through regulation of the cell cycle pathway. Collectively, the sorafenib DS-related prognostic signature may serve as an independent prognostic biomarker and predictor of sorafenib sensitivity in HCC, while the combination of sorafenib and ciclesonide represents a promising strategy to improve targeted therapy.

RevDate: 2026-11-13
CmpDate: 2026-11-12

Chen S, Ye H, Lin B, et al (2026)

Tetrahedral DNA nanostructure-gated solution-phase CRISPR/Cas12a system for probe immobilization-free, reagent-efficient, and dual-phase electrochemical detection of circulating microRNAs in liquid biopsy.

Journal of nanobiotechnology, 24(1):.

Liquid-biopsy nucleic acid biomarkers hold strong promise for non-invasive cancer diagnostics, yet their ultralow abundance presents substantial analytical challenges. Conventional electrochemical biosensors rely on complex probe immobilization, whereas emerging homogeneous strategies remain susceptible to matrix interference and require large reaction volumes. Here, we report a probe immobilization-free, reagent-efficient, dual-phase electrochemical platform that integrates solution-phase CRISPR/Cas12a reactions with a tetrahedral DNA nanostructure (TDN)-based interfacial gating mechanism for detecting circulating microRNAs. We found that TDNs extended with a thiolated blocking fragment (BF) impose a pronounced steric gating effect at the electrode-solution interface: the large, rigid TDN architecture prevents intact BF-linked structures from approaching the gold electrode, whereas smaller Cas12a-generated thiolated fragments readily assemble via Au-S interactions. This size-dependent gating transition switches the electrode from an HRP-accessible to an HRP-blocking state, producing a sharply resolved signal decrease that faithfully maps solution-phase cleavage onto an electrochemical readout. Using a target-competitive binding strategy to generate the activator DNA, this interfacial gating mechanism was developed into a robust dual-phase sensing platform driven by CRISPR/Cas12a. Because target recognition and Cas12a-mediated cleavage occur entirely in solution and only the final reaction products contact the electrode, the architecture retains high homogeneous reaction efficiency while avoiding diffusion-governed limitations and eliminating probe immobilization. The 10 µL reaction volume enables substantial reagent savings and strong compatibility with complex matrices. The assay achieves a detection limit of 4.1 aM and accurately quantifies renal cancer-associated circulating miRNA-21 in peripheral blood, yielding results fully consistent with RT-qPCR.

RevDate: 2026-11-13
CmpDate: 2026-11-12

Hong S, Kim S, Seong JK, et al (2026)

Mitochondrial base editing for disease modeling and therapeutic correction.

Genome biology, 27(1):.

Recent development of mitochondrial DNA (mtDNA) editors has made it possible to generate experimental models carrying patient-relevant mtDNA mutations, characterize disease-associated phenotypes in cells and animals, and directly correct pathogenic variants in vivo. Here, we summarize the current landscape of mtDNA base editors and discuss key considerations for their application to mitochondrial disease model generation, including target selection, cross-species conservation, editing window constraints, strand bias, sequence-context dependence, and the balance between editing efficiency and safety. We further review strategies for validating mtDNA-edited models at functional, molecular, and organismal levels, and highlight recent studies demonstrating therapeutic rescue in animal models.

RevDate: 2026-11-12
CmpDate: 2026-11-12

Long J, Xie J, Liu F, et al (2026)

RPA-primed droplet-partitioned CRISPR/Cas12a assay for low-copy detection of Candida albicans in vaginal specimens.

Frontiers in cellular and infection microbiology, 16:1960866.

Candida albicans is a major cause of vulvovaginal candidiasis, and sensitive detection of low-abundance fungal DNA remains challenging in clinical specimens. In this study, we developed a two-stage assay combining rapid recombinase polymerase amplification (RPA) with droplet-partitioned CRISPR/Cas12a fluorescence detection. Target DNA was first amplified by RPA for 10 min and subsequently analyzed in vortex-generated polydisperse droplets without microfluidic chip fabrication. Using predefined NTC-based analytical criteria, the operational LoDs were 10 copies/μL for the bulk RPA-Cas12a assay and 1 copy/μL for the droplet-partitioned format under the tested conditions. No cross-reactivity was observed with the tested non-target organisms, including additional clinically relevant non-albicans Candida species. In a preliminary evaluation of 28 residual vaginal swab specimens, the assay showed complete concordance with a routine composite clinical reference using an exploratory cohort-derived droplet-count cutoff. Because the comparator was not species-specific for C. albicans, these findings represent preliminary concordance rather than definitive diagnostic accuracy. The complete workflow was performed within approximately 1 h using basic laboratory equipment. These findings demonstrate that droplet partitioning can improve the low-copy analytical readout of RPA-Cas12a detection and provide a practical approach for qualitative identification of C. albicans DNA in vaginal specimens.

RevDate: 2026-11-12
CmpDate: 2026-11-12

Gong L, Wang J, Zhang Y, et al (2026)

Highly sensitive and specific detection of aminoglycoside resistance methylase gene armA by multiple cross displacement amplification-CRISPR/Cas12a technique.

Frontiers in cellular and infection microbiology, 16:1947114.

INTRODUCTION: The 16S rRNA methylase armA serves as a key molecular determinant conferring high-level resistance to aminoglycoside antibiotics in bacterial pathogens. Development of a rapid and reliable armA gene detection assay will improve surveillance of enzyme-producing strains and support drug resistance control in diverse ecological settings.

METHODS: A multiple cross displacement amplification (MCDA) combined with CRISPR/Cas12a system assay was established to identify armA gene with rapidity, specificity, and sensitivity.

RESULTS: The entire experimental process, including genomic DNA extraction (15 minutes), MCDA reaction (40 minutes), CRISPR/Cas12a-mediated cleavage (5 minutes), and fluorescence detection (10 minutes), can be completed within 70 minutes. In terms of analytical specificity, the assay yielded positive results for all armA-positive isolates and negative results for all non-armA samples. The sensitivity of the MCDA-CRISPR/Cas12a assay reached a detection limit as low as 10 copies/mL of armA-positive plasmid DNA. In 129 cultured clinical isolates validated by whole-genome sequencing, the assay achieved 100% concordance for armA detection.

DISCUSSION: The technique established in this study provides a rapid and accurate diagnostic approach for laboratory-based surveillance of armA in clinical and livestock settings, with future potential for point-of-care adaptation following further simplification and validation.

RevDate: 2026-11-14
CmpDate: 2026-11-12

Nguyen CX, Do PT, TM Tran (2026)

Application of AI-designed OpenCRISPR-1 for highly efficient gene editing in soybean (Glycine max L.) and Nicotiana benthamiana.

Transgenic research, 35(1):.

The widespread application of CRISPR/Cas genome editing for commercial crop improvement is currently hindered by a complex and restrictive intellectual property (IP) landscape. The recent development of OpenCRISPR-1, a fully AI-designed Cas9-like nuclease, provides a promising alternative with an accessible licensing framework; however, its efficacy in dicotyledonous plants remains largely uncharacterized. Here, we report the successful adaptation of the OpenCRISPR-1 system for targeted mutagenesis in soybean (Glycine max L.) and Nicotiana benthamiana. We constructed a plant-optimized binary vector (pBSE-OpenCRISPR-1) and validated its editing capability. In soybean (Glycine max), an Agrobacterium rhizogenes-mediated hairy root transformation assay targeting the GmFAD2-1B gene demonstrated that OpenCRISPR-1 actively induces site-specific mutations. In Nicotiana benthamiana, stable Agrobacterium-mediated transformation targeting the phytoene desaturase homologs (NbPDSa/b) achieved overall editing in 75% of T0 transgenic lines (27/36). Analysis of individual homologs revealed editing rates of 66.7% (24/36) at both the NbPDSa and NbPDSb loci. Complete editing of the target locus occurred in 13.9% of events for NbPDSb and 2.8% for NbPDSa, including one event (2.8%) displaying simultaneous complete editing across all alleles resulting in a visible albino phenotype. Deep amplicon and Sanger sequencing revealed a characteristic mutation profile dominated by small insertions and deletions occurring two to three nucleotides upstream of the PAM. These results demonstrate that the AI-designed OpenCRISPR-1 system is a highly active and versatile nuclease for dicot genome engineering. By providing expanded freedom-to-operate, this tool broadens access to crop trait improvement worldwide.

RevDate: 2026-11-14
CmpDate: 2026-11-12

Del Grosso A, Papini N, De Sarlo M, et al (2026)

A new CRISPR/Cas9 GALC Knockout Cellular Model Reveals Lactosylceramide Accumulation Similar to Twitcher Mice.

Molecular neurobiology, 63(1):.

Krabbe disease (KD) is a lysosomal sphingolipidosis caused by the deficiency of galactocerebrosidase (GALC), leading to profound alterations in sphingolipid metabolism and severe neurodegeneration. While psychosine (Psy) accumulation is a well-established hallmark of KD, emerging evidence suggests that lactosylceramide (LacCer) may also contribute to disease pathogenesis. Here, we generated a novel human oligodendrocytic model of GALC deficiency by CRISPR/Cas9-mediated GALC knockout in MO3.13 cells and used it to investigate sphingolipid alterations associated with impaired GALC activity. GALC[-/-] MO3.13 cells showed a marked reduction in GALC transcript levels and enzymatic activity, confirming the successful establishment of a disease-relevant cellular model. Our results demonstrated that a) GALC knockout MO3.13 cells accumulated Psy and LacCer, and b) LacCer content was increased in the brain and heart isolated from twitcher (TWI) mice, the most widely used spontaneous animal model of KD. In parallel, AKT signalling was evaluated in both systems, supporting a link between LacCer dysregulation and altered cellular signalling pathways. Overall, these findings identify LacCer accumulation as a conserved feature of GALC deficiency across cellular and animal models and support the use of GALC[-/-] MO3.13 cells as a novel in vitro platform to investigate KD pathogenesis and candidate therapeutic strategies.

RevDate: 2026-11-14
CmpDate: 2026-11-12

Wang S, Zhang Z, Luan C, et al (2026)

Structural basis for loop-dependent inhibition by AcrIIC1 anti-CRISPR proteins.

Nature communications, 17(1):.

Most characterized anti-CRISPR proteins act via well-defined core inhibitory mechanisms, yet how auxiliary structural elements modulate and potentiate these canonical processes remains poorly understood. Here, we show that AcrIIC1Boe represses Nme1Cas9 activity through an integrated, loop-coupled regulatory mode. Based on canonical occlusion of the HNH catalytic site, the extended loop of AcrIIC1Boe provides an additional coupled regulatory layer to remodel sgRNA spacer arrangement and R-loop progression, thereby enhancing Cas9 inhibition. Loop deletion largely abrogates robust inhibition, indicating that this loop module is indispensable for full AcrIIC1 inhibitory potency. Consistently, transplantation of this functional loop into the weakly active AcrIIC1Nme1 efficiently elevates its inhibitory performance. Our findings identify a loop-mediated regulatory strategy that potentiates the canonical HNH occlusion mechanism, clarify the structural basis for functional divergence across AcrIIC1 homologs, and offer a modular engineering principle for the rational design and optimization of anti-CRISPR proteins with enhanced potency.

RevDate: 2026-11-14
CmpDate: 2026-11-12

Thi Le XM, Truong VA, Dang QT, et al (2026)

Coupling hfCas13d with Circular gRNA Array Precursors Extends RNA Knockdown and Improves Biocatalysis in Yeast.

Nature communications, 17(1):.

CRISPR-based RNA cleavage holds promise for gene knockdown but its applications in metabolic engineering remain largely unexplored. Here we reconstitute three mammalian CRISPR-based RNA cleavage systems to arrest the intermediate metabolic reactions in the yeast Candida viswanathii to produce hydroxydecanoic acid (HDA), an important nylon precursor. We identify hfCas13d as the optimal effector and next develop a circular guide RNA (CgRNA) precursor architecture to enhance and extend the knockdown of genes involved in HDA production. This hfCas13d/CgRNA precursor platform also represses genes in other yeasts and E. coli, demonstrating broad microbial applicability. Single and dual CgRNA precursor arrays enable multiplexed pathway repression, with dual arrays reducing byproduct formation and increasing HDA titer to 17.8 g/L in shake flasks. Bioreactor fermentation further boosts HDA production to 37.2 g/L. Together, this work establishes hfCas13d/CgRNA as a programmable RNA regulatory platform for engineering microbial cell factories.

RevDate: 2026-11-14
CmpDate: 2026-11-12

Ranjan A, Lu A, Hutton C, et al (2026)

Translating pathogen biology into diagnostic and management strategies for gummy stem blight in cucumber production.

Crop health, 4(1):.

Gummy stem blight (GSB) is a major disease of cucurbits caused by Stagonosporopsis spp. and is increasingly problematic in intensive cucumber production systems, particularly where warm, humid environments favour infection, sporulation and rapid disease spread. GSB can infect vegetative and reproductive tissues and remain latent in fruit for several days before visible symptoms develop, creating a distinctive commercial challenge: disease may be difficult to detect before harvest yet cause significant post-harvest losses, reducing grower and retailer confidence. Compounding these problems, current diagnostic tools for detecting pre-symptomatic infection are often insufficiently validated for species specificity, sensitivity, turnaround time, cost, crude-sample compatibility and practical use by production staff. Many of these limitations reflect the relative lack of genomic resources for Stagonosporopsis. Therefore, this review integrates evidence from other pathosystems with current knowledge of Stagonosporopsis taxonomy, infection biology, epidemiology, diagnostics, fungicide resistance, effector biology and host resistance to identify pathways towards grower-ready tools. Specifically, we focus on how recent advances in genomics, paired with previously designed detection systems such as loop-mediated isothermal amplification (LAMP) and clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins (CRISPR/Cas), could be adapted for species-specific detection of the causal pathogen and, simultaneously, provide a regional profile of fungicide resistance. In parallel, we explore how a deeper functional genomic understanding of the disease, particularly of effector proteins expressed during the early stages of infection, could provide valuable insights into the dynamics of this host-pathogen interaction and support strategies to disrupt these interactions through novel fungistatic compounds and the development of disease-resistant cultivars. Together, these approaches could support a staged technology-development and adoption roadmap for more precise, rapid and sustainable GSB management in cucumber production.

RevDate: 2026-11-14
CmpDate: 2026-11-12

Liu H, Rui K, Wang T, et al (2026)

Deciphering the landscape of human pathogenome in non-typhoidal Salmonella through multidimensional genomics.

BMC microbiology, 26(1):.

BACKGROUND: Non-typhoidal Salmonella (NTS) is a leading foodborne pathogen causing severe gastrointestinal and systemic infections, posing a significant global health burden. This study employed a genomic approach to investigate the functional and distribution characteristics of human pathogenome in NTS, aiming to provide molecular targets and a theoretical foundation for novel anti-salmonellosis strategies.

RESULTS: Analysis of eight NTS strains revealed 2,000 virulence genes encoding 263 factors, predominantly effector delivery systems (41%), of which type III secretion system (T3SS) genes constituted the majority (66.3%). A total of 217 partial sequences from 13 salmonella pathogenicity islands (SPIs) were identified, with SPI-2 (26.7%), SPI-1 (24%), and SPI-13 (10.6%) being most prevalent. Key virulence genes in SPI-1 (35 T3SS1-related genes), SPI-2 (30 T3SS2-related genes), and SPI-5 (sopB/sigD, pipB) were conserved across all strains. We identified 7,868 human pathogenicity-related genes, functionally enriched in metabolic/cellular processes, catalytic activity, and binding. Human pathogenicity-related virulence genes were mainly classified as delivery systems, adhesion factors, and nutrient metabolism factors. Enzymatic analysis showed human pathogenicity-related protease genes were primarily serine, cysteine, and metallopeptidases, while human pathogenicity-related carbohydrase-active genes were associated with glycoside hydrolases, glycosyltransferases, and carbohydrate esterases. Functional annotation with the Kyoto Encyclopedia of Genes and Genomes indicated human pathogenicity-related protease genes enrichment in signaling, cellular, metabolic, and genetic information processing pathways, particularly in antibiotic resistance and infectious diseases, while human pathogenicity-related carbohydrase-active genes were enriched in carbohydrate metabolism and glycan biosynthesis. A structurally conserved, metal-chelating non-ribosomal peptide metallophore (NRP-metallophore) gene cluster was present in all strains, containing biosynthetic virulence genes (entA, entC, entF, entB, entE, fes) and transport-related virulence genes (fep family, entS). Functional type I-E clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) systems with variable numbers of CRISPR arrays but conserved direct repeats were identified in most strains.

CONCLUSIONS: NTS strains carried conserved T3SS effectors, human pathogenicity-related factors enriched in metabolism, catalysis, antibiotic resistance, and infection pathways, a conserved NRP-metallophore gene cluster for iron acquisition, and a functional type I-E CRISPR-Cas system, collectively defining key genetic determinants for pathogenesis.

RevDate: 2026-11-13
CmpDate: 2026-11-13

Cao L, He Y, Li W, et al (2026)

A self-driven probiotic nanosystem reshapes extracellular matrix by knockdown of DDR1 for enhanced tumor immunotherapy.

Journal of nanobiotechnology, 24(1):.

Immunotherapy represents a promising therapeutic approach for tumor suppression, yet its efficacy is significantly limited by the immunosuppressive extracellular matrix (ECM) characteristic of solid tumors. To achieve simultaneous ECM remodeling and immune activation within a single system, we have developed a self-driven probiotic nanosystem (PL@LDH-CB) based on the probiotic Clostridium butyricum (CB), which incorporates a plasmid-loaded layered double hydroxide (PL@LDH) gene-editing module. Following intravenous administration, the PL@LDH-CB system actively targets tumor sites by leveraging CB's natural tropism toward hypoxic conditions, thereby efficiently delivering the PL@LDH gene-editing module for ECM reshaping. Within tumors, CB and its metabolites significantly enhance anti-cancer immune responses. Concurrently, the released PL@LDH enables stable nuclear expression of CRISPR-Cas9, precisely knocking down Ddr1-a gene encoding discoidin domain receptor 1 (DDR1) that mediates immune exclusion through promoting collagen fibrillogenesis and fiber alignment. The depletion of DDR1 ultimately reduces intratumoral solid stress (a compressive force exerted by collagen fibers), leading to comprehensive ECM remodeling. This process markedly improves the infiltration of activated T cells within tumors, thereby significantly enhancing immunotherapeutic outcomes.

RevDate: 2026-11-16
CmpDate: 2026-11-16

Lee S, Jung C, Kim M, et al (2026)

Optimized Cas9-Enriched Nanopore Sequencing and Analysis Workflow for Clinical Diagnosis of Repeat Expansion Disorders.

Advanced science (Weinheim, Baden-Wurttemberg, Germany), 13(64):.

Short tandem repeat (STR) expansion is a major genetic mechanism underlying numerous neurogenetic disorders. However, traditional PCR amplification and short-read next-generation sequencing-based methods often fail to detect large-scale, complex expansions and to capture methylation information. Thus, this study aimed to modify an amplification-free nanopore Cas9-targeted sequencing (nCATS) platform to achieve uniform coverage across 56 currently defined STR loci using a single test with genomic DNA from patient-derived blood cells and to develop a dedicated analysis algorithm, STRiker, capable of identifying internal motif contexts and de novo repeat structures. Ultimately, this study identified pathogenic repeat expansions in 12 of 37 patients (32.4%) with cerebellar ataxia who remained genetically undiagnosed despite extensive prior genetic testing, in FGF14 (n = 4), ATXN8OS, NOP56, RFC1 (n = 2 each), and PRNP and NOTCH2NLC (n = 1 each). Additionally, family-based cascade screening revealed six relatives with repeat expansions in five families. These results demonstrate a broader diversity of pathogenic repeat structures, particularly in FGF14, and illustrate that CpG methylation can mitigate the pathogenic effects of repeat expansions. This nCATS-STRiker workflow offers a powerful strategy for improving the diagnosis of STR-related neurogenetic diseases, such as cerebellar ataxia and other diseases.

RevDate: 2026-11-16
CmpDate: 2026-11-16

Shao S, H Zhang (2026)

Single-Molecule Imaging of Endogenous RNA Using a Miniaturized and Circularly Permuted CRISPR-Cas13 Degron-Masking System CDegSR.

Advanced science (Weinheim, Baden-Wurttemberg, Germany), 13(64):.

Visualizing the spatiotemporal dynamics of endogenous, unmodified RNA within living cells is crucial for understanding gene regulation. Yet, existing techniques are often hindered by high background fluorescence and the steric hindrance posed by CRISPR effectors. To address this, we developed CDegSR (CRISPR-mediated Degron-based Signal Restoration), a compact, fluorogenic system for high-contrast RNA imaging at single-molecule resolution. By miniaturizing dPspCas13b to its essential recognition lobe and employing circular permutation, we repositioned the protein termini to enable target-dependent masking of a potent degron. This approach promotes rapid proteasomal degradation of effectors not bound to targets while selectively stabilizing those attached to target RNA. Using CDegSR, we achieved single-molecule tracking of endogenous POLR2A transcripts, revealing that nuclear crowding and the translation machinery are the main physical constraints on mRNA mobility. CDegSR provides a versatile, low-perturbation toolkit for dissecting the transcriptomic lifecycle at single-molecule resolution.

RevDate: 2026-11-16
CmpDate: 2026-11-16

Chen R, Coquelin ML, Srirattana K, et al (2026)

A multiplex genome editing pipeline for rapid combinatorial trait engineering.

Cell reports methods, 6(11):101572.

Current de-extinction efforts center on editing the genomes of extant species to express key traits that evolved in closely related extinct species. These complex projects require advances in genetic engineering pipelines coupled with animal model production as an approach to test hypotheses about genotype and phenotype associations. Here, we establish a multiplex genome engineering pipeline capable of introducing up to eleven genomic modifications across seven different genes simultaneously in viable founder mice. Our workflows achieved high editing efficiencies spanning three genome-editing modalities: Cas9 knockout, Cas9-mediated homology-dependent repair (HDR), and cytosine base editing and included editing of zygotes and embryonic stem cells. As a proof of concept, we produced six mouse models with modifications in genes involved in hair development and lipid metabolism, and the resulting mice displayed predicted hair phenotypes including curly, textured coats, and gold hair. This study advances methods of rapid establishment of complex genetic models, with a wide array of applications.

RevDate: 2026-11-16
CmpDate: 2026-11-16

Hu B, Chen L, Wang R, et al (2026)

Integrated Organoid CRISPR Screening Reveals NF1 as a Gatekeeper of Cervical Squamous Malignant Transformation.

Cancer research, 86(22):5641-5666.

UNLABELLED: Cervical cancer can progress from high-grade squamous intraepithelial lesions driven by persistent human papillomavirus (HPV) infection. Identifying the gatekeepers restraining malignant transformation could reveal strategies to prevent and treat cervical cancer. In this study, we integrated single-cell transcriptomics, CRISPR-Cas9 screening, and organoid modeling to dissect this process. Single-cell analysis of patient samples revealed progressive activation of rat sarcoma virus (RAS) and proliferation programs along epithelial differentiation paths. A focused CRISPR screen in HPV-positive pretumoroids identified neurofibromin 1 (NF1) as the top suppressor of malignant transition. NF1 loss accelerated carcinogenesis in organoids, substantially shortening the experimental interval required for the emergence of malignant phenotypes and recapitulating basal cell expansion, altered differentiation marker expression, and tumorigenicity. Mechanistically, NF1 loss enhanced RAS-mitogen-activated protein kinase and phosphoinositide 3-kinase-protein kinase B signaling, promoted proliferative programs, and remodeled chromatin accessibility at regulatory regions enriched for activator protein 1 motifs. Conversely, NF1 restoration in cancer organoids induced apoptosis and suppressed malignant maintenance. Artificial intelligence-guided modeling was used to design a minimal NF1-derived peptide predicted to interact with RAS GTP-binding protein. The NF1-GAP-mimetic peptide reduced tumor organoid viability and cervical lesion-associated bioluminescence in an HPV16-driven mouse model and was associated with local immune-related changes without marked alterations in selected splenic T-cell populations. Together, these findings establish NF1 as a critical constraint on HPV-associated epithelial evolution and provide a time-compressed organoid model of cervical carcinogenesis, offering proof of concept for NF1-inspired therapeutic interception of RAS-associated signaling.

SIGNIFICANCE: Single-cell atlas and organoid screening identified NF1 loss as a driver of cervical carcinogenesis, which can be rescued with an AI-designed NF1 mimetic peptide that offers a therapeutic paradigm to intercept tumorigenesis.

RevDate: 2026-11-16
CmpDate: 2026-11-16

Zhang H, Li Y, Wang Y, et al (2026)

Hybridization-Mediated Reversible sgRNA Caging Enables Tumor-Selective Gene Editing for Potentiating Antitumor Immunity via cGAS Demethylation.

Angewandte Chemie (International ed. in English), 65(47):.

Spatiotemporal precision remains a critical challenge against the gene editing technology used for disease treatment. We herein developed a tumor cell-selective CRISPR/Cas9 gene editing system by introducing a complementary single-stranded DNA (ssDNA) containing apurinic/apyrimidinic (AP) sites (AP-ssDNA) along the target region of single-guided RNA (sgRNA). The engineered hybrid (AP-ssDNA/sgRNA) could tracelessly release the native sgRNA in tumor cells due to cleavage of AP-ssDNA by the overexpressed apurinic/apyrimidinic endonuclease 1 (APE1), thus enabling tumor-selective gene editing. Subsequently, a biodegradable lipid nanoparticle based on dynamic covalent bonding was developed to codeliver Cas9-encoding mRNA (mCas9) with AP-ssDNA/sgRNA targeting the SUV39H1 gene, which mediated silence of cyclic GMP-AMP synthase (cGAS) methylation to activate stimulator of interferon genes (STING) and enhanced antitumor immunity. As thus, when coupled with radiotherapy, the gene editing platform provoked robust antitumor efficacy in B16F10 xenograft tumor-bearing mice. This study provides a versatile paradigm for conditionally controlled gene editing and highlights the therapeutic potential of cGAS demethylation in reactivating cGAS-STING pathway for antitumor immunotherapy.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Wimmer T, Arbeiter ML, Lytvynchuk L, et al (2027)

Quantification of Prime Editor-Corrected Frameshift Mutations Using Bioluminescence Resonance Energy Transfer (BRET).

Methods in molecular biology (Clifton, N.J.), 3099:177-186.

Frameshift mutations, caused by insertions or deletions of nucleotides that disrupt the coding reading frame, often result in premature stop codons, terminating protein translation. Prime editing, a precise genome-editing tool, has demonstrated remarkable efficiency in correcting such mutations even in living organisms. Prime editors are fusion proteins that combine a nickase variant of Cas9 (nCas9; H840A), which induces single-strand nicks in double-stranded DNA, with a modified reverse transcriptase. This system uses an extended guide RNA (pegRNA) that includes a primer-binding site and a reverse transcriptase template for the desired edit. Bioluminescence Resonance Energy Transfer (BRET) quantifies molecular interactions via energy transfer from a luminescent donor to a fluorescent acceptor. In this context, BRET is employed to measure the correction of frameshift mutations by restoring acceptor fluorophore expression. The donor luciferase coding sequence, located upstream of the frameshift mutation, remains unaffected and serves as an internal standard, ensuring reliable quantification independently of experimental fluctuations.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Ren X (2027)

Functional Analysis of Genetic Variants Using High-Throughput Prime Editing Screening.

Methods in molecular biology (Clifton, N.J.), 3099:187-199.

Prime editing is a precise genome editing technology that introduces edits, deletions, and insertions at single-base resolution. This protocol describes the design and execution of pooled high-throughput prime editing screens in mammalian cells. Using this approach, thousands of genetic variants can be tested simultaneously. The effects of tested genetic variants on cellular phenotypes are measured using high-throughput DNA sequencing of pegRNAs/ngRNAs as barcodes.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Prajogo RC, Han MLB, JK Lee (2027)

TAPE-seq: A Cell-Based Method for Genome-Wide Off-Target Prediction in Prime Editing.

Methods in molecular biology (Clifton, N.J.), 3099:213-225.

Prime editors are powerful genome-editing tools that enables precise sequence modifications without the need for double-strand breaks or donor DNA templates. Given their distinct mechanism of action, evaluating their off-target activities is essential for ensuring safety in ongoing clinical development. Unlike Cas9-based tools that predict off-target effects indirectly, TAPE-seq directly leverages PE activity to map genome-wide off-target sites with high sensitivity and specificity. This detailed protocol provides a robust framework for evaluating the safety of PE-based genome-editing applications.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Gupta A, B Yang (2027)

Plant Prime Editing: Design, Assembly, and Application.

Methods in molecular biology (Clifton, N.J.), 3099:243-252.

Prime Editing (PE) is the latest technological advancement in genome editing. With the capabilities of altering the genome with precision and efficiency, PE offers great advantages over conventional CRISPR-Cas9 as well as base editors to achieve all 12 possible base changes and small indels. However, the complicated design and assembly of prime editing constructs is a limiting step in the wider applicability of the technology. In this chapter, we set forth step-by-step protocols aimed at helping the scientific community in designing their constructs as well as assembling them to target up to four genes. With the availability of PE plasmids and design/assembly protocols, PE in plants can be carried out by more labs across the globe to recognize the great potential of PE in their research.

RevDate: 2026-11-15
CmpDate: 2026-11-15

Gu S, Wang N, Tu Y, et al (2027)

Replicon engineering-driven modular synthetic biology toolkit for efficiently iterative genome editing in Fusarium venenatum.

Metabolic engineering, 99:102559.

Fusarium venenatum is the most widely used filamentous fungus for biomass-based microbial protein production mainly used as meat analogs. However, insufficient iterative genome editing and lack of synthetic biology tools for fine-tuning gene expression limited engineering of F. venenatum for improved traits. Here, replicon engineering-based modular synthetic biology toolkit in F. venenatum was established. Specifically, stable and curable mitochondrial DNA-derived replicons were firstly identified and characterized. The curable replicon MT07 enabled CRISPR/Cas9 genome editing system with efficient plasmid curing, shortening curing time from 22 to 8 days. Based on genome editing system, six neutral genomic integration sites were identified for gene integration expression. In contrast, the stable replicon MT071 enabled stable episomal expression system construction, facilitating the characterization of modular transcriptional and translational regulatory elements, including 21 promoters, 8 terminators, 9 Kozak sequences, and 2A peptide-mediated polycistronic expression modules, yielding 662.9-fold gene expression dynamic range. As a proof of concept, this toolkit was applied to engineering the chassis cell and construct 3-hydroxy-3-methylbutyrate (HMB) biosynthetic pathway, enabling efficient co-production of microbial protein and HMB, with titers reaching 36.2 g/L and 6.2 g/L, respectively. Overall, this work establishes a replicon engineering-driven synthetic biology platform to engineer filamentous fungi for sustainable food biomanufacturing.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Zheng C, W Xue (2027)

Large Insertion Using Template-Jumping Prime Editing.

Methods in molecular biology (Clifton, N.J.), 3099:145-151.

Prime editors (PEs) are advanced gene-editing tools capable of a wide spectrum of genomic modifications, offering significant potential for gene therapy. The template-jumping prime editing (TJ-PE) system employs template-jumping prime editing guide RNAs (TJ-pegRNAs) with a dual primer binding site (PBS) sequence. One PBS anneals to the DNA flap generated by the TJ-pegRNA, while the other binds to the DNA flap generated by the nicking sgRNA, enabling the accurate insertion of large DNA fragments.

RevDate: 2026-11-14
CmpDate: 2026-11-14

Fagbohun OF, Olawoye B, Oriyomi OV, et al (2026)

Dual-site CRISPR/Cas9-mediated mutations in Toll-like receptor 4 (TLR4): complete characterization reveals divergent autophagic reprogramming of LPS-related downstream activities.

International journal of biological macromolecules, 381(Pt 1):153947.

Lipopolysaccharide (LPS) initiates hyperinflammatory cascade via the LBP-CD14-MD2-TLR4 complex which can precipitate fatal cytokine storms and septic shock. We aim to develop molecular strategies that selectively dampen TLR4-driven inflammation without eliminating host defense. Here, we demonstrate that CRISPR-Cas9-mediated dual-site editing of the TLR4 gene, by introducing specific disruptions in both the extracellular domain (ECD) and the intracellular Toll/IL-1 receptor (TIR) domain, can generate a partially uncoupled signaling phenotype that selectively attenuates acute inflammation while preserving baseline stress-adaptive mechanisms. By combining whole-genome and amplicon-based next-generation sequencing, RNA-Seq, molecular dynamics simulations, transmission electron microscopy (TEM), GSEA, and functional reporter assays, we show that targeted mutations near the LPS-binding interface within the LRR modules of the ECD (M209I, V254I, E593D) and within the CD loop of the TIR domain (R761H) reduce ligand binding-pocket volume by ~17% (688.19Å[3] vs. 825.41Å[3]) within TLR4 loci, leading to partial signal propagation and altered LPS trafficking to lysosomal compartments through autophagosome sequestration. Immunofluorescence profiling revealed broad attenuation of TLR-signaling networks, MyD88/TRAF6 recruitment, and downstream NFκB-MAPK-PI3K-AKT-JAK-STAT-mTOR cascades alongside decreased CD14 expression, suppressed ROS generation, and diminished caspase-3 activity. While complementary NFκB and LC3-HiBiT reporter assays confirmed interrupted LPS-induced inflammatory transcription and conventional autophagic flux activation, TFEB reporters revealed that edited macrophages remain highly sensitive and responsive to direct metabolic mTOR-dependent metabolic inhibition via Rapamycin. Collectively, our findings establish TLR4 as a central molecular switch and suggest that CRISPR-Cas9-mediated dual-site editing reprograms macrophages into repair-oriented, adaptive phenotype with implications for therapeutic strategies targeting inflammation, sepsis, and autophagy-driven tissue protection.

RevDate: 2026-11-14
CmpDate: 2026-11-14

Malekpouri M, S Lotfi (2027)

CRISPGen: A deep generative framework for multi-objective CRISPR/Cas9 guide RNA design via Conditional Latent Diffusion and Dual-Critic Reinforcement Learning.

Computational biology and chemistry, 126(Pt 1):109328.

MOTIVATION: The CRISPR-Cas9 system offers transformative potential for precision genome editing, yet its clinical translation remains constrained by the risk of unintended off-target double-strand breaks. While current discriminative models excel at evaluating pre-specified candidate guides, resolving the fundamental antagonism between on-target cleavage efficiency and off-target specificity within a fixed sequence search space remains a major challenge.

RESULTS: We present CRISPGen, a unified deep generative framework that reframes sgRNA design as a multi-objective constrained sequence synthesis problem. It integrates (i) DNABERT-2 genomic-language embeddings, (ii) a conditional latent diffusion generator conditioned on a user-specified on-target efficiency target, and (iii) a dual-critic reinforcement-learning (RL) stage that couples a frozen on-target efficiency critic with a cross-attention off-target discriminator (validation Pearson R=0.8157) trained on a unified corpus of experimental off-target events from six detection platforms. Across 1000 generated sgRNAs, CRISPGen reduces the mean off-target discriminator score by 99.7% relative to the pre-RL baseline and, under an exhaustive whole-genome screen of all 302,631,056 NGG PAM sites in GRCh38, yields zero perfect-match and only 55 one-mismatch genomic hits. We further show, transparently, that the internal on-target critic saturates under RL optimization - an instance of Goodhart's Law - and therefore assess on-target viability using an independent external CRISPRon screen (mean 47.10/100). Repeating the RL fine-tuning stage under three random seeds (with the diffusion generator, DNABERT-2 embeddings, and off-target discriminator held fixed) yields a stable operating point across seeds. Full diversity, per-mismatch, and reproducibility statistics are reported in the Results.

AVAILABILITY: Source code is available at https://github.com/malekpouri/CRISPGen; the pre-trained checkpoints and the 3,000,000-sequence library are hosted on Hugging Face (https://huggingface.co/malekpouri/CRISPGen-Checkpoints) and archived on Zenodo under DOI 10.5281/zenodo.21428641.

RevDate: 2026-11-14
CmpDate: 2026-11-14

Zhou N, Ma Y, Wang Y, et al (2026)

T7 Ribonucleic Acid Polymerase-Triggered CRISPR/Cas13a and Branched HCR Cascade Amplification with Machine Learning for SERS Detection of Cardiac Troponin I.

ACS applied materials & interfaces, 18(44):61616-61628.

Cardiac troponin I (cTnI) serves as a critical biomarker of acute myocardial infarction (AMI). Its serum level is extremely sparse, and the clinical cut-off value reaches merely 0.2 ng mL-1. This poses a significant challenge, requiring highly sensitive analytical techniques for reliable quantification. This study proposes a powerful surface-enhanced Raman scattering (SERS) sensing strategy integrating multistage signal amplification and machine learning to enhance detection performance. By combining T7 RNA polymerase, CRISPR/Cas13a, branched hybridization chain reaction (bHCR), and Fe3O4@COF@Ag magnetic substrate, the strategy constructs an efficient "recognition-amplification-signal output" closed loop for cTnI detection. Experimental results demonstrate that the platform has a linear calibration range of 0.1-104 pg/mL for cTnI, with an estimated limit of detection (LOD) of 0.1 pg/mL, holding promise for future AMI-related biomarker analysis. It also shows excellent selectivity against common serum interferents, good reproducibility (intra-batch RSD = 2.87%, inter-batch RSD = 7.96%), and reliable recovery (100.1%-110%) in human serum samples. Based on Raman signals, the k-nearest neighbor (kNN) classifier demonstrated high accuracy in classifying cTnI concentration levels, while the artificial neural network (ANN) model exhibited strong quantitative predictive performance with an R2 of 0.9997. This platform overcomes the limitations of conventional cTnI assays in terms of sensitivity and signal amplification efficiency, providing a promising analytical platform for future AMI-related biomarker studies.

RevDate: 2026-11-14
CmpDate: 2026-11-14

MacGregor SR, Bradbury RS, Jones MK, et al (2026)

Development of an accurate CRISPR/Cas13 diagnostic system for Wuchereria bancrofti.

Emerging microbes & infections, 15(1):2761170.

Disease surveillance is critical for WHO's Global Programme to Eliminate Lymphatic Filariasis (LF), but current field-ready diagnostics exhibit insufficient sensitivity and/or specificity in low-endemic settings. We aim to develop an ultra-sensitive and field-friendly CRISPR/Cas13-based SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) tool for point-of-care detection of Wuchereria bancrofti infection. The SHERLOCK assay, combining recombinase polymerase amplification (RPA) with CRISPR/Cas13a detection, was performed in two-step and one-pot formats, with sensitivity compared to qPCR (the emerging gold standard). The W. bancrofti SHERLOCK assays achieved a detection limit of 0.1 fg/μL gBlock DNA and showed no cross-reaction with five other filarial species. Assays were validated using 149 pooled mosquito and 185 human blood samples from Samoa, which were previously tested for LF antigen using WHO-recommended Filariasis Test Strips (FTS) and microscopically examined for microfilariae (Mf). For both mosquito and human samples, the two-step SHERLOCK assay reached 100% sensitivity and specificity, while one-pot SHERLOCK showed 94.0-96.4% sensitivity and 100% specificity. To improve the field deployability of the assay, we also used lyophilized one-pot SHERLOCK master mix and assessed its thermostability after storage at 25, 4, and -20°C. The lyophilized one-pot SHERLOCK mix maintained a detection limit of 10 fg/μL W. bancrofti gBlock after 10 days at 25°C, indicating reduced reliance on cold-chain for reagent storage and transport. However, when testing human blood samples with lyophilized SHERLOCK, reduced sensitivity (59.7%) was observed. This CRISPR-based platform offers a promising field-ready next-generation approach to LF diagnostics, potentially addressing current limitations, enhancing surveillance, and elimination efforts.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Santos Sousa I, Patrício D, Torres M, et al (2027)

pegRNA Online Tool Design and Experimental Assembly: Exploring the Practical Use of PE-Designer for Prime Editing.

Methods in molecular biology (Clifton, N.J.), 3099:9-29.

Prime editing (PE) is an innovative genome-editing technology that enables precise genetic modifications with greater efficiency compared to traditional CRISPR/Cas9-based systems. The successful application of this method heavily depends on the design of prime editing guide RNAs (pegRNAs). Efficient design of pegRNAs is facilitated by online tools like PE-Designer (www.rgenome.net/pe-designer/) , which offers a user-friendly interface for designing pegRNA and nicking single-guide RNA (sgRNA) sequences. Notable features of PE-Designer include its flexibility in adjusting the prime binding site (PBS) and reverse transcription template (RTT) lengths of pegRNAs, as well as its ability to assess potential off-target effects across various genomes. This chapter focuses on using PE-Designer for pegRNA design, providing a step-by-step guide to the tool while addressing frequent challenges. Furthermore, using the SnapGene software, we explore the assembly of both the pegRNA and sgRNA construct maps. Finally, the chapter presents the experimental protocol for constructing both the pegRNA and sgRNA vectors, with a detailed explanation of the Golden Gate assembly technique.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Lee G, HK Kim (2027)

Design of Highly Efficient pegRNAs with Minimized Off-Target Effects Using DeepPrime.

Methods in molecular biology (Clifton, N.J.), 3099:31-40.

Prime editors are newly developed genome editing tools capable of installing various types of mutations without introducing double-strand DNA breaks (DSBs) or requiring donor DNA templates. Prime editors consist of a Cas9 nickase fused to a reverse transcriptase (RT) domain and function as a ribonucleoprotein complex with prime editing guide RNA (pegRNA). Unlike the single guide RNA (sgRNA) used with Cas9 or base editors, the editing efficiency of pegRNAs is determined by the sequence composition and length of the guide sequence, primer binding site (PBS), and reverse transcription template (RTT). The high design flexibility of pegRNAs presents both opportunities and challenges. Therefore, designing pegRNAs with high efficacy has been a significant hurdle for the application of prime editing. Here, we present a step-by-step protocol for designing optimal pegRNAs to introduce desired edits using a deep learning-based algorithm, DeepPrime.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Gould SI, FJ Sánchez-Rivera (2027)

Using Prime Editing Guide Generator (PEGG) for High-Throughput Generation of Prime Editing Sensor Libraries.

Methods in molecular biology (Clifton, N.J.), 3099:41-54.

Prime editing enables the generation of nearly any small genetic variant. However, the process of prime editing guide RNA (pegRNA) design is challenging and requires automated computational design tools. We developed Prime Editing Guide Generator (PEGG), a fast, flexible, and user-friendly Python package that enables the rapid generation of pegRNA and pegRNA-sensor libraries. Here, we describe the installation and use of PEGG (https://pegg.readthedocs.io) to rapidly generate custom pegRNA-sensor libraries for use in high-throughput prime editing screens.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Oliynyk RT, GM Church (2027)

Rapid Cell-Free Preparation of Circular Vector DNA for pegRNA Expression in Prime Editing.

Methods in molecular biology (Clifton, N.J.), 3099:55-66.

The expression of prime editing guide RNA (pegRNA) is crucial for effective CRISPR-Cas9 prime genome editing, traditionally facilitated by DNA plasmids, which require a time-consuming process of bacterial cloning, validation, and purification. The Circular Vector (CV) protocol represents an efficient, fully synthetic, cell-free method that bypasses these traditional steps, allowing for the preparation of pegRNA expression vectors within 3 h. This approach involves circularizing and purifying linear double-stranded DNA (dsDNA) templates containing a promoter with pegRNA elements into compact, bacterial-backbone-free vectors. These CVs offer significant advantages: absence of a bacterial backbone, absence of endotoxins, and no contamination by bacterial nucleic acids, making them a superior choice for transfection in cell culture experiments, where they have shown performance equal to or better than that of traditional plasmids. The CV protocol not only speeds up the preparation process but also reduces costs and complexity, making it an ideal tool for rapid and efficient pegRNA expression in research settings.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Zhang G, Huang X, J Liu (2027)

Construction of the p2PE3 Platform Based on RNA-Pol-II-Driven Engineered pegRNA.

Methods in molecular biology (Clifton, N.J.), 3099:67-85.

Prime editor (PE) is a versatile tool capable of precisely installing programmed genetic information into eukaryotic genomes. The canonical PE3 system uses a constitutive RNA polymerase III (RNA-Pol-III) promoter to drive RNA expression. However, RNA-Pol-III is unable to efficiently transcribe RNA sequences containing poly(T) motifs or gRNAs expressed in tandem, which restricts the application of PE. Here, we detail the use of an RNA polymerase II (RNA-Pol-II) promoter to drive RNA expression, coupled with Csy4 for RNA processing. This approach enabled efficient editing with poly(T)-containing pegRNAs, multiple gRNA editing combinations, and conditionally inducible gRNA. These findings overcome the limitations of RNA-Pol-III-driven RNA systems and broaden the applications of prime editing.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Jang G, Kweon J, Y Kim (2027)

Protocol for Prime Editing with Engineered PAM-Flexible Cas9 Variants.

Methods in molecular biology (Clifton, N.J.), 3099:87-104.

Prime editing (PE) is a precision genome-editing technology that allows all types of editing, such as substitutions, insertions, and deletions, at the target site in the genome of a cell without double-strand breaks (DSBs) or donor DNA. However, the targeting range of existing prime editing systems is limited due to their dependence on the NGG protospacer adjacent motif (PAM) recognized by Streptococcus pyogenes Cas9 (spCas9). To address this limitation, we have engineered prime editor variants incorporating PAM-flexible Cas9 proteins. These variants significantly expand the range of targetable genomic sites, allowing for the introduction of mutations previously inaccessible to standard editing methods. Here, we provide detailed methods for applying these PAM-flexible PE variants in human cell lines.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Liao LZ, KJ Wu (2027)

Improvement of Genome Editing Efficiency in Mammalian Cells by a Refined Uni-Vector Prime Editing System.

Methods in molecular biology (Clifton, N.J.), 3099:105-113.

Prime editing is an advanced technology in the CRISPR/Cas genome editing field. The original multi-vector method utilized in prime editing has less efficiency and precision and is also inherently difficult in generating homozygous mutations in mammalian cells. To overcome these technical difficulties, a Uni-vector prime editing system containing the major components for prime editing has been constructed in two all-in-one plasmids, pPE3-pPuro and pePE5max-pPuro. The Uni-vector prime editing plasmids enhance the editing efficiency of prime editing and improve the generation of homozygous mutated mammalian cell lines. The editing efficiency depends on the transfection efficiency. Remarkably, the Uni-vector ePE5max system can achieve a high editing rate even in cell lines that are traditionally difficult to transfect. This Uni-vector approach simplifies the delivery of all the necessary editing components and greatly improves the editing efficiency. This approach represents an advanced progress in the field of prime editing.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Matsui K, Niwa R, Endo S, et al (2027)

Optimization and Evaluation of Prime Editing Activity in Human iPSCs.

Methods in molecular biology (Clifton, N.J.), 3099:115-132.

Human induced pluripotent stem cells (iPSCs) retain the genetic information of their donors, making them invaluable for modeling genetic diseases and for isogenic controls. Precise genome editing in iPSCs is essential to realizing this potential. However, efficient precision editing of iPSCs remains challenging due to the lack of direct enrichment strategies for edited cells carrying subtle mutations such as small insertions and deletions (indels) or single-nucleotide variants (SNVs). Previously, we demonstrated that fluorescence-activated cell sorting (FACS) can indirectly enrich cells with ssODN-templated edits by selecting those with high plasmid-based co-expression of Cas9 and mCherry. While effective, editing approaches relying on Cas9-induced double-strand breaks (DSBs) increase the risk of on-target byproducts, emphasizing the need for alternative strategies. Prime editing offers DSB-free precision editing by using a Cas9 nickase fused to a reverse transcriptase to install edits encoded in prime editing guide RNAs (pegRNAs). Here, we present both plasmid-based and mRNA-based prime editing protocols to generate precise edits evaluated using a GFP-to-BFP conversion assay. The plasmid method is cost-effective and allows for FACS-based enrichment of edited cells, while the mRNA method minimizes genomic integration risk while improving editing efficiencies without the need for enrichment. Together, these methods provide robust platforms for efficient precision editing in human iPSCs, facilitating downstream functional genomics and therapeutic applications.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Theodore K, Tahir S, Costa BLD, et al (2027)

All-in-One Prime Editing System for Efficient Generation and Isolation of Single Edited hiPSC Clones.

Methods in molecular biology (Clifton, N.J.), 3099:133-143.

Prime editing has emerged as the preferred gene-editing technique due to its versatility and precision in introducing genetic modifications such as single-base pair substitutions, insertions, and deletions without the need for double-strand breaks (DSBs) and a donor template. Thus, substantially reduces the likelihood of off-target effects that are generally produced when using the traditional CRISPR-Cas9 system. Here, we describe an in-depth protocol for the generation and isolation of prime-edited single human induced pluripotent stem cell (hiPSC) clones. In this example, we transfect a commercial hiPSC line with an all-in-one prime editor plasmid to install a pathogenic PRPH2 mutation using the PE3 approach.

RevDate: 2026-11-12
CmpDate: 2026-11-12

Qin W, Lin SJ, Zhang Y, et al (2026)

High-efficiency TadA cytosine base editors for precise modelling of human disease variants.

Nature biomedical engineering, 10(11):2363-2378.

Many missense mutations identified in genetic testing are variants of uncertain significance (VUS), not yet classified as either benign or pathogenic. Systematic determination of their functional relevance is a pressing clinical need. CRISPR-mediated base editing can precisely introduce precise variants into model organisms for functional testing, but current editors face efficiency and targeting constraints. We developed TCBE-Umax, a family of TadA-derived cytosine base editors optimized for zebrafish. Engineering the TadA deaminase domain improved editing efficiency and reduced sequence-context bias, expanded PAM compatibility, and minimized bystander edits and indel formation. Our editors achieved efficient biallelic editing, enabling rapid functional assessment of genetic variants in the F0 (founding) zebrafish. As a proof of concept, we evaluated 15 VUS linked to hereditary hearing loss, determining pathogenicity through phenotypic analysis. With high efficiency and versatility, TCBE-Umax base editors provide a powerful platform for studying genetic variants and disease in vivo.

RevDate: 2026-11-12
CmpDate: 2026-11-12

Yu T, Ji M, Yu D, et al (2026)

Structure-guided discovery and engineering of miniature CRISPR-Cas12m for epigenome editing.

Nature structural & molecular biology, 33(11):1624-1639.

CRISPR-based epigenome editing represents a programmable strategy to precisely modulate gene expression, holding promise for therapeutic applications. However, the large size of dCas proteins substantially impedes delivery using adeno-associated virus (AAV) vectors. Here, through iterative bioinformatics analysis, structure-guided predictions and functional assays, we identified and characterized a miniature subtype V-M CRISPR-Cas12m from Pelomicrobium methylotrophicum. PmCas12m exhibited flexible 5'-YTN-3' PAM-dependent recognition and robust double-stranded DNA-binding properties while lacking DNA cleavage activity, thus rendering it a valuable tool for epigenome editing. Cryo-electron microscopy structures of PmCas12m unveiled its molecular mechanism of target DNA binding. Guided by these structural insights, we used deep mutational scanning and protein engineering to develop xCas12m, a hypercompact variant with highly potent and specific epigenome-editing capabilities in human cells. We further constructed the xCas12m-CRISPRoff platform in a single AAV vector, which achieved durable epigenetic silencing and effective inhibition of hepatitis B virus infection in a mouse model. Collectively, these findings establish xCas12m as a versatile epigenome-editing platform with notable potential for treating diseases, paving the way for clinical translation of epigenetic therapies.

RevDate: 2026-11-13
CmpDate: 2026-11-13

Freed G, Quijada-Álamo M, Lee L, et al (2026)

A CRISPR-based humanized model reveals a cooperative role of STAG2 loss in familial GATA2-deficient MDS progression.

Blood advances, 10(22):7690-7701.

Myelodysplastic syndrome (MDS) is a heterogeneous myeloid malignant neoplasm driven by hematopoietic stem cell dysfunction, leading to ineffective hematopoiesis and cytopenias. Familial GATA2 deficiency is the most common cause of MDS in adolescents, with progression often accelerated by co-occurring mutations, notably STAG2 loss of function. Using CRISPR/Cas9-mediated genome engineering in primary human fetal liver-derived hematopoietic stem cells and xenotransplantation in mice, we modeled GATA2-deficient MDS with acquired STAG2 loss to investigate disease initiation and progression. Although GATA2 deficiency alone had minimal short-term impact in our model, combined GATA2 deficiency and STAG2 loss increased hematopoietic stem cell maintenance and self-renewal, induced a myeloid-lineage bias, and expanded primitive progenitors. Single-cell transcriptional profiling revealed upregulation of stemness-associated genes and inflammatory pathways. This humanized model faithfully recapitulates high-risk GATA2-deficient MDS, providing mechanistic insights into how cooperative mutations drive stem cell expansion, inflammatory signaling, and myeloid skewing.

RevDate: 2026-11-13
CmpDate: 2026-11-13

Nagahara M, Namula Z, Hirata M, et al (2027)

Laparoscopic transfer of in vitro fertilized gene-edited embryos in pigs.

Theriogenology, 268:118244.

Laparoscopic embryo transfer in pigs has been explored as a minimally invasive alternative to conventional laparotomic methods, which often lead to surgical risks such as adhesions, prolonged recovery, and postoperative complications. This study is the first to report the generation of genetically modified pigs via embryo transfer using a laparoscopic approach. Gene-edited embryos were prepared by delivering the CRISPR/Cas9 system via electroporation to target the Coagulation Factor VIII, WDR45, and IL2RG genes and then transferred into the oviducts of five recipient gilts using a laparoscopic technique. Embryos putatively carrying modifications in the Coagulation Factor VIII and WDR45 genes were each transferred into a single recipient gilt, and both recipients became pregnant. In contrast, embryos putatively carrying a modification in the IL2RG gene were transferred into three recipient gilts, of which two became pregnant. In total, four recipient gilts were carried to full term, resulting in the birth of 9 live piglets. Genotyping confirmed that all of the offspring carried the genetic modifications, demonstrating this method may have potential for producing genetically modified pigs. The successful production of live gene-edited offspring demonstrates the feasibility of laparoscopic embryo transfer for genetically modified embryos. Although further research, including a large number of recipient pigs, as well as direct comparisons with conventional laparotomy, is needed to evaluate embryo survival, implantation efficiency, and animal welfare, laparoscopic embryo transfer represents a feasible approach for generating genetically modified pigs.

RevDate: 2026-11-12
CmpDate: 2026-11-12

Komatsu D, Hiraizumi M, Fell CW, et al (2026)

Structural mechanism of programmable gene integration by the R2 retrotransposon coupled with CRISPR-Cas9.

Nature structural & molecular biology, 33(11):1640-1653.

R2 retroelements are non-long-terminal-repeat retrotransposons that primarily insert into 28S ribosomal DNA loci across diverse eukaryotes. R2 elements home to their target sites through target-primed reverse transcription (TPRT), in which the R2 protein recognizes and nicks the target DNA to prime reverse transcription using an R2-encoding RNA as the template. The avian R2 system from Taeniopygia guttata (R2Tg) can insert a payload sequence within an RNA template into 28S ribosomal DNA loci in human cells. Here, we present cryo-electron microscopy structures of the R2Tg-template RNA-target DNA complex in the TPRT initiation state, both alone and bound to a Cas9-guide RNA complex. These structures provide mechanistic insights into R2Tg-mediated TPRT in its natural context and in the programmable gene integration system STITCHR (site-specific target-primed insertion through targeted CRISPR homing of retroelements). Furthermore, we combine these structural insights with computational protein design methods to engineer an enhanced STITCHR system.

RevDate: 2026-11-11
CmpDate: 2026-11-11

Capelli L, Hao Y, Shi Q, et al (2026)

Programming CRISPR Compartmentalization on DNA Origami for Multiplexed Biosensing.

Analytical chemistry, 98(44):31052-31062.

CRISPR-Cas12a has emerged as a transformative tool for nucleic acid detection and molecular diagnostics. However, achieving one-pot, orthogonal, multiplexed sensing remains challenging due to the nonspecific trans-cleavage activity of Cas12a. Here, we present a modular DNA origami-based platform that spatially confines and independently controls Cas12a activity, enabling simultaneous detection of multiple DNA targets within a single reaction. This spatial programming approach enables orthogonal one-pot detection of three DNA targets (EGFR L858R/Del19 mutations and HPV16) with minimal cross-talk, demonstrating 60% cleavage efficiency within 120 min at 100 nM. Through integrated molecular dynamics simulations and experimental validation, we identify an optimal ∼6 nm spatial window that maximizes cleavage efficiency, while the platform maintains robust performance in complex biological environments with a 10 nM detection limit in 20% serum. This compartmentalization strategy establishes a framework for spatially programming multi-enzyme systems on DNA nanostructures for synthetic biological circuits.

RevDate: 2026-11-11
CmpDate: 2026-11-11

Li H, Zhou Y, Yan Y, et al (2026)

Decoupled Signal Transduction via a Non-Copper Laccase Mimic for CRISPR-Based Electrochemical Detection of Hepatocellular Carcinoma.

Analytical chemistry, 98(44):31469-31484.

Laccase-mimicking nanozymes have been overwhelmingly copper-dependent, and largely confined to environmental contexts, with clinical translation remaining unrealized. Here, we depart from this paradigm by designing a non-copper nanozyme, Mn-Trp NR, assembled through manganese-tryptophan coordination. Spectroscopic and theoretical analyses show that tryptophan coordination finely modulates the Mn electronic structure, strengthening O2 adsorption and lowering the reaction barrier, thereby conferring laccase-like activity, substrate affinity, and stability superior to the native enzyme. To overcome broad-substrate promiscuity that precludes specific biomarker recognition, we decoupled signal transduction from target identification: Mn-Trp NR serves as a universal amplifier, whereas CRISPR/Cas12a confers high specificity. Accordingly, a cascaded electrochemical biosensor was built on a DNA triangular prism integrating catalytic hairpin assembly, hybridization chain reaction, and CRISPR/Cas12a activation. The platform detects hepatocellular carcinoma (HCC) biomarkers microRNA-122 (miRNA-122) and alpha-fetoprotein (AFP) with limits of 11.98 aM and 10.31 fg/mL, respectively, in a streamlined 160 min, two-step procedure. In clinical sera, the biosensor perfectly distinguishes HCC patients from healthy donors (AUC = 1.00) and agrees strongly with benchmark methods (RT-qPCR for miRNA-122, ELISA for AFP, R2 > 0.97). By expanding laccase-mimic synthesis beyond copper via ligand-field engineering and establishing a decoupled architecture that reconciles broad-spectrum catalysis with high-specificity recognition, this work provides a generalizable strategy for deploying nanozymes in precision diagnostics.

RevDate: 2026-11-11
CmpDate: 2026-11-11

Zhou S, Xiang T, Cha Z, et al (2026)

A Two-Step Strategy Based on Fpg Recognition and RCA-CRISPR/Cas12a for Ultrasensitive Detection of Gene Mutation.

Analytical chemistry, 98(44):30873-30882.

Accurate detection of gene mutations is crucial for acute myeloid leukaemia (AML) diagnosis and treatment. Although CRISPR/Cas systems enable sensitive mutation detection, their adaptability is constrained by dependence on restriction endonucleases. Herein, we propose a two-step strategy, termed Fpg-RCA-CRISPR/Cas12a for ultrasensitive detection of the p53 R175H, which integrates formamidopyrimidine DNA glycosylase (Fpg)-mediated recognition with rolling circle amplification (RCA)-coupled CRISPR/Cas12a technology. Validation confirmed that Fpg exhibits minimal activity when adenine (A) is opposite the damaged site. Based on this finding, we designed a padlock probe with a site-specific 8-oxoguanine (8-oxoG) modification. This modification enables selective recognition of G > A mutations. For the target TP53 c.524G > A (p53 R175H), the G > A substitution opposite the 8-oxoG site blocks Fpg cleavage, facilitating probe circularization and subsequent RCA. The resulting RCA products then activate the trans-cleavage activity of Cas12a, enabling cascade signal amplification and generating a strong fluorescence output. For wild-type p53, Fpg-mediated cleavage prevents circularization and amplification, yielding weak fluorescence. Taking advantage of the high specificity of the Fpg enzyme and the cascade amplification effect of the RCA-CRISPR/Cas12a system, this method achieves a limit of detection (LOD) of 0.29 fM and covers a linear range from 0.8 fM to 800 pM, along with high reproducibility, excellent selectivity, and negligible background interference. Notably, the assay can detect mutation frequencies as low as 0.1% in excess wild-type p53. Crucially, its clinical feasibility was confirmed by analyzing human serum samples, yielding results consistent with standard assays and thus demonstrating its practical reliability and translational potential.

RevDate: 2026-11-11
CmpDate: 2026-11-11

Hou XY, Li MY, Sun WB, et al (2026)

Modular Cell-Surface-to-Solution CRISPR-Cas12a Platform for Wash-Free Quantification of Cell-Surface Proteins on Living Cells.

Analytical chemistry, 98(44):31528-31541.

Cell-surface proteins are important biomarkers for cell phenotyping, disease diagnosis, therapeutic evaluation, and drug screening. However, their quantitative analysis on intact living cells remains challenging because conventional methods often require cell lysis, fixation, repeated washing, extensive sample processing, or bulky instrumentation. Herein, we developed a modular and reconfigurable cell-surface-to-solution CRISPR-Cas12a platform for wash-free quantitative analysis of cell-surface proteins on intact living cells. Aptamer recognition of extracellularly accessible targets deblocks a DNA activator, thereby activating Cas12a trans-cleavage in solution and converting localized cell-surface recognition into amplified fluorescence while maintaining a low background in the absence of targets. Using EpCAM as a model target, we engineered a split dual-aptamer architecture that enabled cooperative target recognition, efficient activator deblocking, and low-background signal amplification. The platform achieved sensitive EpCAM detection with a limit of detection of 32 fM and enabled live-cell analysis down to 2 cells/μL. It distinguished cell populations with different surface EpCAM levels and quantitatively monitored epithelial-mesenchymal transition-associated changes in cell-surface EpCAM abundance. Coordinated redesign of the target-responsive nucleic acid components extended the platform to PTK7 detection and the analysis of drug-induced cell-surface PTK7 remodeling. Coupling the system to a lateral flow readout enabled portable visual detection. This work establishes a modular and reconfigurable CRISPR-Cas12a sensing strategy for wash-free amplified quantification of cell-surface proteins on living cells, providing a convenient tool for investigating their dynamic remodeling during physiological and pathological processes and therapeutic responses, as well as for drug screening.

RevDate: 2026-11-12
CmpDate: 2026-11-11

Mao W, L Zhang (2026)

Microfluidic Biosensors for the Detection of Foodborne Pathogens: A Comprehensive Review.

Food science & nutrition, 14(11):e72588.

Foodborne pathogen detection in complex foods remains challenging because sample preparation and signal readout can be affected by lipids, proteins, and background microorganisms. This review compares microfluidic biosensors by substrate, fabrication route, sample handling, and optical, electrochemical, or nucleic-acid readout. Published studies demonstrate rapid detection in selected food samples, but reported detection limits cannot be compared without their matrices, units, enrichment steps, and assay times. Laboratory performance also does not establish field readiness. Reproducible manufacture, reagent stability, integrated sample-to-answer operation, and validation in authentic foods remain major translational barriers. Orthogonal readouts, CRISPR-assisted assays, and AI-supported interpretation are promising, but their benefit over simpler methods requires direct comparison and independent validation. Future studies should report matrix-specific recovery and performance, test robustness across sites, and address usability, cost, and regulatory requirements before claiming commercial readiness.

RevDate: 2026-11-12
CmpDate: 2026-11-11

Ma X, Li L, Y Sun (2026)

CRISPR Technology: From Bench to Bedside Applications.

MedComm, 7(11):e71011.

CRISPR-Cas genome editing represents one of the most transformative advances in modern molecular biology, enabling programmable site-specific genetic modification that has revolutionized functional genomics and precision therapeutic development. Beyond canonical Cas9 nucleases, the CRISPR toolkit has diversified into precision base editors, prime editors, CRISPR-associated transposases, and Cas12/Cas13 RNA-targeting effectors, each with distinct mechanistic properties. Clinically, ex vivo CRISPR therapies for hemoglobinopathies have secured regulatory approval, while base editing, prime editing, and in vivo Chimeric Antigen Receptor (CAR)-T candidates are advancing through trials for a broad spectrum of hematologic, oncologic, and rare genetic disorders. However, existing reviews largely address technical innovation or clinical translation in isolation, lacking a holistic, up-to-date synthesis of the full bench-to-bedside trajectory of CRISPR technology. This review systematically dissects the molecular mechanisms, advantages, and limitations of core CRISPR editing platforms; summarizes pivotal clinical data across hemoglobinopathies, CAR-T immunotherapy, muscular dystrophy, cystic fibrosis, cardiometabolic diseases and rare monogenic diseases; evaluates delivery systems including lipid nanoparticles and viral vectors; and discusses key translational barriers such as off-target genotoxicity and immunogenicity alongside emerging optimization strategies. This work provides a holistic bench-to-bedside framework for CRISPR research, offering critical insights to advance next-generation precision genetic medicine.

RevDate: 2026-11-11

Gomase VS, Nimje HM, Kale S, et al (2026)

Next-Generation Mycobacterium tuberculosis Diagnostics: A Systematic Review of Molecular, CRISPR, and Biosensor Technologies.

Recent patents on biotechnology pii:BIOT-EPUB-159546 [Epub ahead of print].

INTRODUCTION: TB (tuberculosis) due to Mycobacterium tuberculosis continues to be a significant worldwide health issue. Timely and reliable diagnostic tests will improve treatment outcomes and reduce the spread of disease. Traditional TB diagnostics currently available, such as smear microscopy and culture, have significant limitations with regard to sensitivity and turnaround times, especially for smear-negative cases and for tuberculosis in extrapulmonary locations.

OBJECTIVES: The purpose of this review is to analyze the evolution of TB diagnostics from traditional microbiology to new molecular diagnostic methods (including CRISPR, biosensor technology, and microfluidic methods), including an assessment of their diagnostic testing performance, feasibility, and potential for the future.

METHODS: The systematic narrative review aimed to systematically assess literature published from 2020 to 2025 retrieved from PubMed, Scopus, Web of Science, IEEE Xplore, ScienceDirect, and Google Scholar. The review was carried out according to the PRISMA guidelines and included 89 studies after screening and assessing for eligibility. The data were analysed qualitatively (i.e., through thematic analysis) by comparing data from conventional, molecular, and next-generation diagnostic methods.

RESULTS: Molecular tests (e.g., GeneXpert, Line Probe Assays, PCR, and Whole Genome Sequencing) provide greater sensitivity and specificity than traditional methods and allow for faster diagnosis. Additionally, newer CRISPR-based tests, biosensors, and microfluidic devices hold promise for rapid, portable, point-of-care diagnosis of tuberculosis.

DISCUSSION: The findings indicate that molecular diagnostics improve rapid detection and drug-resistance profiling, while CRISPR and biosensor platforms offer potential for rapid point-of-care testing. However, affordability, infrastructure, clinical validation, and scalability remain important barriers.

CONCLUSION: The use of molecular diagnostic testing, CRISPR technology, biosensors, artificial intelligence, and portable platforms will dramatically enhance existing TB surveillance systems and strategies for controlling the disease globally.

RevDate: 2026-11-11
CmpDate: 2026-11-11

El-Sehrawy AAMA, Sapaev I, Nematov O, et al (2026)

Mapping Osteosarcoma Biology With CRISPR/Cas: From Gene Function to Therapeutic Targets.

Cell biology international, 50(11):.

Osteosarcoma is a highly aggressive primary bone malignancy characterized by rapid proliferation, chemoresistance, and early metastasis. Recent advances in CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) genome editing have enabled precise targeting of oncogenes, tumor suppressors, and regulators of epigenetic, metabolic, and signaling pathways, providing new insights into osteosarcoma biology. CRISPR-mediated knockout of cell-cycle regulators, including CDK11, impairs proliferation, while restoration of TP53 and suppression of TERT promoter activity inhibits tumor growth. Other line of studies has revealed that chemoresistance mechanisms mediated by ABCB1/MDR1, CD44, ATR, RAD18, and autophagy-related genes have been effectively reversed through CRISPR interventions, restoring sensitivity to cisplatin and doxorubicin. Furthermore, CRISPR applications in immune modulation, such as PD-L1 knockout, may enhance antitumor immunity. Importantly, high-throughput CRISPR screens also may identify essential genes, novel oncogenic drivers, and synthetic lethal targets, thus informing potential precision therapeutic strategies. This review aims to critically summarize CRISPR/Cas-mediated studies in osteosarcoma, focusing on targeting oncogenes and tumor suppressors, overcoming chemoresistance, modulating immune responses, regulating metabolism and autophagy, and identifying essential genes and vulnerabilities, providing a translational framework for precision therapy.

RevDate: 2026-11-11
CmpDate: 2026-11-11

Du R, Wang W, Xie J, et al (2026)

Clustered Regularly Interspaced Palindromic Repeats-Cas Genome-Editing Systems in Filamentous Fungi: Current Tools, Optimization Strategies, and Future Perspectives.

Journal of agricultural and food chemistry, 74(44):34662-34682.

Filamentous fungi are important microbial cell factories for producing antibiotics, organic acids, enzymes, and other valuable products, with broad applications in food, agriculture, and medicine. However, inefficient and imprecise genome editing remains a major bottleneck limiting rational strain engineering. This review summarizes major genome-editing tools in filamentous fungi, including Cre-loxP, TALENs, and CRISPR-Cas systems, with emphasis on their mechanisms, advantages, and limitations. We highlight CRISPR-Cas9 as the predominant platform and discuss optimization strategies involving sgRNA design, engineered Cas9 variants, promoter engineering, AMA1-based replicative plasmids, and ribonucleoprotein delivery. Emerging technologies, including base editing, prime editing, Cas12a, and Mad7, are also discussed for their potential to broaden editing capabilities. Finally, we outline future perspectives focusing on extending the application of existing genome-editing systems in filamentous fungi and discovering novel genome-editing tools from large-scale omics data sets. This review will accelerate the development of filamentous fungi as versatile platforms for biomanufacturing.

RevDate: 2026-11-11
CmpDate: 2026-11-11

Yang H, Zhang H, Zhao Z, et al (2026)

Tumor-Specific Gene Editing Enhances Cancer Immunogenicity through Succinate Metabolism-Mediated MHC-I Reprogramming.

Journal of the American Chemical Society, 148(44):48152-48167.

Impaired expression of major histocompatibility complex class I (MHC-I) greatly compromises cytotoxic T-cell-mediated anticancer immunotherapy. Existing MHC-I activation strategies are greatly challenged by poor tumor specificity and off-target toxicity. Herein, we report a dual tumor-specific CRISPR/Cas9 gene editing system that can precisely knock out succinate dehydrogenase subunit C (Sdhc) to activate the MHC-I pathway via epigenetic and transcriptional regulation. A tumor-specific gene editor is first engineered via reversible shielding of sgRNA using an apurinic/apyrimidinic endonuclease 1 (APE1)-responsive, complementary ssDNA, yielding AP-sgRNA with blocked editing activity in normal cells yet completely restored activity in APE1-overexpressing tumor cells. Subsequently, tumor-targeted delivery of AP-sgRNA and Cas9 mRNA (mCas9) is achieved using dibenzocyclooctyne-decorated lipid nanoparticle (DLNP), which upon bioorthogonal click reaction can anchor cancer cells that are prelabeled with azido groups using the unnatural sugar DCL-AAM. Thus, AP-sgSdhc/mCas9@DLNP enables efficient and selective Sdhc editing in tumor cells, leading to epigenetic and transcriptional activation of MHC-antigen processing and presentation genes and thereby provoking robust antitumor efficacy in the B16-OVA melanoma model through enhanced, T cell-mediated immune responses. Moreover, it completely suppressed pulmonary metastasis after combination with aPD-L1 in the 4T1 lung metastasis model. This study provides an enlightened paradigm for precision gene editing and renders a promising mechanism for potentiating cancer immunotherapy.

RevDate: 2026-11-11
CmpDate: 2026-11-12

Berry AM, Costa BLD, PMJ Quinn (2027)

Prime Editing: Mechanism and Developments.

Methods in molecular biology (Clifton, N.J.), 3099:1-7.

Prime editing is a "search and replace" based genome editing method that can introduce point mutations, insertions, and deletions into DNA at desired sites, making it the editing technique capable of making the most diverse range of edits. Prime editing utilizes a Cas9 nickase fused to a reverse transcriptase to introduce edits encoded by a specially designed DNA oligonucleotide called a prime editing guide RNA (pegRNA). While prime editing has been shown to achieve robust editing in different genomic loci and in different cell types, this technology still has the potential for further optimization and improvement. Many groups have been successful in improving prime editing outcomes by optimizing the design of prime editors and pegRNAs. Additionally, modulating key cellular pathways has also been an effective tool for achieving high levels of editing. Due to its high efficiency and relative safety, prime editing has the potential to transform disease modeling and genomic medicine.

RevDate: 2026-11-12
CmpDate: 2026-11-11

Levesque S, Kawashima N, Hwang GH, et al (2026)

Targeted genomic integration and rearrangement using prime assembly.

Nature, 659(8140):532-541.

Although therapeutic genome editing holds great potential to remedy diverse inherited and acquired disorders, targeted installation of medium-to-large genomic modifications in therapeutically relevant cells remains challenging[1]. Here we develop prime assembly, an approach that permits DNA sequence assembly and integration in human cells leveraging CRISPR-targeted dual flap synthesis. This method enables RNA-programmable site-specific integration of single or double-stranded DNA fragments. Unlike homology-directed repair, prime assembly is similarly active in dividing and non-dividing cells. We applied prime assembly to perform targeted exon recoding, transgene integration and megabase-scale rearrangements, including at therapeutically relevant loci in primary human cells. Prime assembly expands the capabilities of genome engineering by enabling the targeted integration of medium to large-sized DNA sequences without relying on double-stranded DNA donors, nuclease-driven double-strand breaks or cell cycle progression.

RevDate: 2026-11-12
CmpDate: 2026-11-12

Zhou H, Wang YZ, Zhang SM, et al (2026)

Targeting FAK-YAP Signaling Axis Inhibits Tumor Stemness and Overcomes Tumor Resistance to Cuproptosis.

Advanced materials (Deerfield Beach, Fla.), 38(63):.

Cuproptosis has recently been identified as a novel metabolic cell death pathway that holds great promise for cancer therapy. However, cuproptosis resistance developed by tumor cells severely impairs its anticancer efficacy. Here, our study uncovers that the FAK-YAP signaling axis in tumor cells plays important roles in the development of cuproptosis resistance and the promotion of tumor stemness. To therapeutically target this signaling axis, a CRISPR-cuproptosis synergistic nanoplatform (CPLNP@HA) is elaborately designed for targeted co-delivery of a Ptk2 (encoding FAK) CRISPR-Cas9 knockout plasmid to block FAK-YAP signaling axis and Cu-elesclomol (Cu-ES, a cuproptosis inducer) into tumor cells. Mechanistically, CPLNP@HA efficiently silences FAK expression, which subsequently blocks the cuproptosis-induced activation of the FAK-YAP signaling cascade. This intervention not only sustains intracellular copper accumulation to reinforce cuproptosis but also reduces tumor stemness, thereby significantly potentiating the therapeutic outcomes of cuproptosis and activating tumoricidal immunity as evidenced by transcriptomic analysis. In combination with immune checkpoint blockade therapy, CPLNP@HA markedly inhibits tumor development upon rechallenge after surgical resection. Our work establishes FAK-YAP signaling axis as a new therapeutic target to overcome cuproptosis resistance and inhibit tumor stemness, providing a promising combinatorial paradigm to sensitize tumor to cuproptosis and immunotherapy.

RevDate: 2026-11-12
CmpDate: 2026-11-12

Zhang Y, Deng F, Sang R, et al (2027)

Functional double-emulsion droplets enable multiplexed CRISPR quantification of cancer-related miRNAs.

Biosensors & bioelectronics, 317:119361.

Accurate, multiplexed microRNA detection is critical for early cancer diagnosis. We present a droplet-based digital CRISPR/Cas13a platform for simultaneous, amplification-free detection of multiple miRNAs. By integrating double emulsion (DE) microfluidics with programmable crRNAs, the system achieves orthogonal, interference-free readouts, enabling precise absolute quantification in complex biological samples. The assay demonstrates high sequence specificity, robust orthogonality, and consistent performance across target combinations and matrices. Fluorescence-positive droplet counts correlate linearly with input concentrations, allowing quantification of miRNA-21, miRNA-29a, and miRNA-92a with 10 copies/μL representing the lowest concentration experimentally evaluated in this study. The applicability of the platform is further evaluated in a small proof-of-concept cohort of plasma samples from healthy controls and colorectal cancer (CRC) patients. This platform provides an amplification-free approach for multiplexed miRNA quantification and supports further development for clinical biomarker analysis.

RevDate: 2026-11-08
CmpDate: 2026-11-05

Alam S, Matvienko D, Boström J, et al (2027)

A modular lentiviral system for multiplexed gene perturbation and functional analysis suggests interdependence of hormone receptors in breast cancer growth in vivo.

Life science alliance, 10(1):.

Precise and flexible control of gene expression is essential for dissecting gene function in complex biological systems. Although recent developments in genetic engineering and CRISPR/Cas9 technology have expanded tools for gene activation, suppression, and editing, their application in physiologically relevant models remains challenging, time-consuming, and expensive. Here, we present a modular, doxycycline-inducible vector system that integrates gene overexpression, shRNA-mediated knockdown, and CRISPR/Cas9-mediated regulation within a single, lentivirus-compatible system. The modular design allows rapid exchange of selection markers, epitope tags, and reporters via Gateway cloning, providing broad adaptability across experimental settings. In addition to standard fluorescent and luminescent reporters, the system includes advanced sensors, such as Fucci cell cycle reporters, to enable monitoring of cellular processes. By combining fluorescence barcoding with combinatorial genetic perturbations, the platform supports multiplexed analysis of gene function and genetic interactions through phenotypic characterization by fluorescence imaging or flow cytometry. We demonstrate its utility in vivo with breast cancer intraductal xenografts, which suggest that ER+ breast cancer cells (MCF7) rely on androgen, estrogen, and progesterone receptors for in vivo growth. This versatile gene perturbation system provides tight temporal control, streamlined implementation, and high-content phenotyping capacity facilitating efficient in vitro and in vivo studies while reducing the use of animals in in vivo validation experiments. It thus expands the experimental repertoire for dynamic, multigene interrogation in complex systems.

RevDate: 2026-11-07
CmpDate: 2026-11-05

Xie Q, Ma L, Wang Z, et al (2026)

From immunity to identity to exaptation: RNA-based self/non-self discrimination across cellular life.

BMC immunology, 27(1):.

Distinguishing self from non-self is a universal imperative of life, where such discrimination at RNA level is both evolutionarily rational and urgently required to maintain homeostasis. Across kingdoms, organisms have evolved distinct yet convergent strategies to achieve this goal. Animals broadly employ A-to-I mRNA editing and other modifications as self-tags; plants and fungi mainly rely on RNA interference, spatial segregation, and m[6]A methylation; and prokaryotes utilize CRISPR-Cas immunity as a programmable analog of self-recognition. Despite their efficacy, these systems harbor intrinsic vulnerabilities that viruses might exploit through mimicry and modification theft, perpetuating a dynamic host-pathogen arms race. During evolution, these defense mechanisms might be exapted for new roles in hosts: A-to-I editing diversified proteomes, and m[6]A methylation became a global regulator of mRNA fate. Together, these observations reveal that mechanisms born from conflict might be repurposed to drive molecular innovation, linking self-recognition, adaptation, and the evolution of complexity.

RevDate: 2026-11-07
CmpDate: 2026-11-06

Guo J, Wu T, Qiao Q, et al (2026)

Development of a One-Step RT-LAMP-CRISPR/Cas12b Assay for Rapid On-Site Detection of Dabie Bandavirus.

ACS omega, 11(43):66547-66556.

Severe fever with thrombocytopenia syndrome (SFTS), caused by Dabie bandavirus (DBV), has rapidly spread to multiple countries worldwide since its discovery in 2009, posing a serious threat to global public health security. SFTS is a tick-borne disease, and people living in mountainous and hilly areas are at increased risk of infection, which highlights the urgent need for rapid, accurate, and field-applicable diagnostic strategies for DBV. In this study, LAMP primers and CRISPR sgRNA were designed based on the conserved region of the DBV L segment. A one-pot, one-step molecular assay integrating reverse transcription loop-mediated isothermal amplification (RT-LAMP) with CRISPR/Cas12b technology was established after systematic optimization of key parameters. The assay operates under isothermal conditions at 60 °C, delivering results within 40 min. Analytical evaluation demonstrated a limit of detection of 25.6 RNA copies per reaction. No cross-reactivity was observed with Hantaan virus, Seoul virus, Chikungunya virus, Japanese encephalitis virus, Dengue virus, and Zika virus. Clinical validation using 42 specimens showed complete concordance with gold-standard qRT-PCR, achieving 100% sensitivity (30/30) and 100% specificity (12/12). For point-of-care application, fluorescence visualization was incorporated into the CRISPR/Cas-based detection workflow, enabling straightforward result interpretation. This integrated RT-LAMP-CRISPR/Cas12b platform provides rapid and specific detection of DBV through a simplified workflow that does not require complex instrumentation, supporting its potential application in resource-limited environments.

RevDate: 2026-11-07
CmpDate: 2026-11-06

Khan A, Iqbal A, Athar H, et al (2026)

Mutation-induced penicillin binding protein 2A inactivation through CRISPR-dCas9 gene editing in methicillin-resistant S. aureus.

Iranian journal of microbiology, 18(5):741-751.

BACKGROUND AND OBJECTIVES: The global rise of antimicrobial resistance threatens effective treatment of bacterial infections. Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen whose resistance to β-lactam antibiotics is primarily mediated by the mecA gene, encoding the low-affinity penicillin-binding protein PBP2a. This study aimed to investigate whether CRISPR-dCas9-mediated targeting of mecA could suppress resistance-associated gene expression and restore β-lactam susceptibility in MRSA.

MATERIALS AND METHODS: Seven target sites within mecA, comprising two non-coding and five coding regions, were selected for CRISPR-dCas9 targeting. The effects of gene interference were evaluated using antibiotic disk diffusion assays, minimum inhibitory concentration (MIC) testing with gradient E-strips, RT-PCR, and Sanger sequencing.

RESULTS: Targeting non-coding regions suppressed mecA transcription and reduced PBP2a production, whereas targeting coding regions generated mutations associated with dysfunctional PBP2a. CRISPR-dCas9 treatment significantly reduced mecA expression and increased MRSA susceptibility to β-lactam antibiotics, particularly ampicillin and cefixime. MIC values decreased by up to 12-fold and 6-fold, respectively (p<0.05).

CONCLUSION: CRISPR-dCas9-mediated targeting of mecA effectively reduced β-lactam resistance in MRSA. This approach demonstrates potential for precision-based antimicrobial resistance management and warrants further investigation as a strategy for combating drug-resistant bacterial infections.

RevDate: 2026-11-08
CmpDate: 2026-11-06

Moyer SM, Ilic N, Gang S, et al (2026)

MYC primes a paralog synthetic lethality involving the mitochondrial translocase subunits TIMM17A and TIMM17B and N-Acetylaspartate.

Science advances, 12(45):eaej2662.

To identify the genes and pathways required for the survival of MYC-amplified cancers, we engineered an isogenic cell system in which transformation is driven by oncogenic MYC. Using a genome-scale CRISPR-Cas9 library, we identified the mitochondrial membrane translocase TIMM17A as uniquely essential for the survival of MYC-transformed cells. This dependency arises from MYC-driven suppression of TIMM17B, the paralog of TIMM17A. TIMM17A/B is an essential component of the TIM23 mitochondrial protein import complex, and the MYC-induced suppression of TIMM17B creates a strong dependency on TIMM17A. N-acetylaspartate supplementation rescued TIMM17A dependency in MYC-amplified cell lines, highlighting the unique and crucial role of this metabolite in the cell fitness of MYC-amplified cancers. These observations identify a paralog dependency required for the survival of a subset of MYC-driven cancers.

RevDate: 2026-11-06

Marti E, González-Villalobos E, JL Balcázar (2026)

Editorial: Bacteriophages and CRISPR-Cas for combating multidrug-resistant bacteria.

RevDate: 2026-11-09
CmpDate: 2026-11-07

Gao S, Ullah U, Jin J, et al (2026)

Comprehensive molecular characterization and biosafety assessment of TaDOF7.6 transgenic and gene-edited wheat.

BMC plant biology, 26(1):.

BACKGROUND: Wheat is one of the major staple food crops worldwide, and stable wheat yield is crucial for ensuring global food security. Transgenic and gene-editing technologies serve as important approaches for wheat genetic improvement, yet further application of related materials requires systematic evaluation of their molecular characteristics, genetic stability and environmental biosafety. In this study, TaDOF7.6-RNAi transgenic wheat and TaDOF7.6-CRISPR/Cas9 gene-edited wheat previously constructed in our laboratory were used as experimental materials to evaluate their yield-related traits, molecular profiles and partial biosafety indicators.

RESULTS: Both RNAi-mediated silencing and CRISPR/Cas9-mediated knockout of TaDOF7.6 significantly improved wheat grain traits and yield-related agronomic traits, further confirming that TaDOF7.6 acts as a negative regulator in wheat yield regulation. For TaDOF7.6-RNAi transgenic wheat, the integration site of T-DNA on wheat chromosome 3B was identified via thermal asymmetric interlaced PCR (TAIL-PCR). Vector-derived fragments including Hyg, GUS and dsRNA were consistently detectable across T3 to T5 generations. Moreover, these RNAi lines maintained stable histochemical GUS activity and sustained silencing efficiency of TaDOF7.6. No significant differences were observed in seed germination, seedling emergence and pollen-related traits between RNAi-25, RNAi-31 lines and wild-type wheat. Within the sampling scope and conventional PCR detection conditions adopted in this research, no target exogenous gene fragments were detected in 24 surrounding plant species. Additionally, there were no obvious disparities in field insect community and weed distribution between transgenic lines and wild-type controls. For TaDOF7.6-CRISPR/Cas9 gene-edited wheat, the insertion locus of exogenous vector on wheat chromosome 4D was successfully mapped. Transgene-free homozygous mutants were acquired through Hi-TOM high-throughput sequencing, Sanger sequencing and progeny screening. No unintended sequence variations were detected at all predicted off-target sites compared with wild-type plants. Meanwhile, the gene-edited lines exhibited consistent performance with wild-type wheat in seed germination, seedling emergence and pollen-associated phenotypes.

CONCLUSION: This study provides fundamental data for molecular characterization and comprehensive biosafety assessment of TaDOF7.6-RNAi transgenic wheat and TaDOF7.6-CRISPR/Cas9 gene-edited wheat, and verifies the application potential of TaDOF7.6 as a promising target gene for wheat yield improvement. The transgene-free gene-edited mutants obtained in this work also supply elite new germplasm resources for subsequent wheat molecular breeding programs.

RevDate: 2026-11-08
CmpDate: 2026-11-07

Li Y, Liu L, Zhang J, et al (2026)

Reprogramming secretion systems in Klebsiella quasipneumoniae: from pathogenic functions to candidate industrial secretion chassis.

Frontiers in bioengineering and biotechnology, 14:1940225.

Efficient extracellular secretion remains a major bottleneck in microbial cell factories, motivating the search for chassis organisms with native high-throughput transport capacity. Klebsiella quasipneumoniae (Kqp), a recently delineated member of the Klebsiella pneumoniae species complex, encodes diverse secretion-related systems, including RND-type efflux pumps, type II and type VI secretion systems (T2SS/T6SS), outer membrane vesicle (OMV) pathways, and capsular polysaccharide (CPS) export machinery. In clinical settings, these systems contribute to opportunistic pathogenicity, antimicrobial resistance, and host adaptation; in biotechnology, they may provide transport modules that can be detoxified and redirected for extracellular production. This review examines the feasibility of reprogramming Kqp from a pathogen-related bacterium into a safe industrial secretion chassis. We summarize the molecular architecture, substrate-recognition logic, and regulatory networks of major secretion pathways, then discuss CRISPR-Cas-driven removal of virulence and resistance determinants, biocontainment, and synthetic-biology strategies for reallocating secretory capacity. We further survey potential applications in bulk chemicals, human milk oligosaccharides, recombinant proteins, and industrial enzymes. Finally, we identify key barriers to industrial translation, including growth-secretion energetic trade-offs, periplasmic protein misfolding, endotoxin-associated downstream processing, OMV heterogeneity, scale-up robustness, and quantitative safety validation. Establishing Kqp as an industrial chassis will require evidence-tiered strain selection, quantitative secretion-capacity measurement, regulatory decoupling of resistance-associated pumps, and One Health-aligned safety assessment. Direct evidence in K. quasipneumoniae remains limited; therefore, this review distinguishes direct Kqp observations from studies in other KpSC members or K. oxytoca, evidence from non-Klebsiella hosts, and forward-looking proposals. OMV yield is considered separately from lipid A/endotoxin-related properties.

RevDate: 2026-11-11
CmpDate: 2026-11-07

Nagar P, Islam MR, Rahman NA, et al (2026)

CRISPR-mediated correction of oncogenic AS-NMD in splicing factor mutant cancer.

Frontiers in immunology, 17:1958532.

Alternative splicing coupled to nonsense-mediated mRNA decay (AS-NMD) evolved as a master regulator of gene expression. Dysregulated AS-NMD has been identified as the root of many human maladies, from developmental defects to deadly cancer. Poison exons (PEs) are highly conserved alternative exons that contain a premature termination codon and elicit AS-NMD when included in a transcript. Cancer cells often exploit the inclusion of PEs to downregulate tumor suppressors or the exclusion of PEs to upregulate oncoproteins. Therefore, PEs have drawn significant attention as a novel therapeutic avenue for cancer and other diseases. It was previously reported that an oncogenic mutation in the splicing factor SRSF2 promotes downregulation of the tumor suppressor EZH2 by including a PE, resulting in altered chromatin regulation, defective hematopoiesis, and cancer development. Here, we examine a therapeutic proof-of-concept for manipulating PE-mediated oncogenic AS-NMD using a CRISPR-based approach. Using paired guide RNA, we successfully deleted the PE of EZH2 from the genome of SRSF2-mutated leukemia. This editing resulted in EZH2 mRNAs without a PE, and restored EZH2 protein expression. This subsequently restored Polycomb Repressive Complex 2 (PRC2) association, and global H3K27 histone methylation. The proposed CRISPR strategy provides compelling evidence for correcting oncogenic PE inclusion, highlighting its potential for therapeutic application against PE in cancer and other human diseases.

RevDate: 2026-11-09
CmpDate: 2026-11-07

Dangelmaier CA, Elzoheiry M, Vajipayajula DN, et al (2026)

Phosphorylation of tyrosine 519 and 520 on Syk is essential for ITAM and hemITAM signaling and function in platelets.

Blood vessels, thrombosis & hemostasis, 3(4):100225.

The protein spleen tyrosine kinase (Syk) plays a central role in immunoreceptor tyrosine-based activation motif (ITAM) and hemi-ITAM signal transduction in numerous hematopoietic cell systems. To assess the mechanism of Syk regulation, the tandem tyrosines 519 and 520 in the kinase domain of mouse Syk were mutated to phenylalanines by CRISPR-Cas. The breeding of these mice did not follow the expected Mendelian ratio, as genotype analysis of pups from heterozygous intercrosses revealed that less than one-tenth were the mutant form of Syk lacking phosphorylation at Y519,Y520 (Syk Y519,520F). On gross examination, the intestines of Syk Y519,520F mice were diffusely reddened, raising suspicion for vascular inflammation. Lymphocytes were reduced by ∼50% in the Syk Y519,520F mice. Aggregation and secretion induced by 2-methyl-thio-ADP or AYPGKF were unaffected in the Syk 519,520F mouse platelets. There was no aggregation or dense-/α-granule secretion when Syk Y519,520F platelets were challenged with any concentration of collagen-related peptide or C-type lectin receptor-2 (CLEC-2) cross-linking. No phosphorylation of the downstream signaling proteins linker of activation of T cells Y220 or phospholipase Cγ2 Y1217 was detected in the mutated platelets. The Syk Y519,520F mutation had a clear effect on hemostasis as evidenced by a significant increase in tail bleeding time and the time to thrombus formation using the ferric chloride injury model. These data reveal that phosphorylation of Y519 and Y520 on Syk after stimulation of either glycoprotein VI or CLEC-2 receptors was crucial for the ability of Syk to transduce a downstream signal to regulate in vivo and ex vivo platelet functions.

RevDate: 2026-11-09
CmpDate: 2026-11-08

Raji S, Soltaninejad H, Hosseinkhani S, et al (2026)

CRISPR/Cas9-Mediated Targeting of the Integrin Beta-2 Gene as a Gene-Editing Strategy for Leukocyte Adhesion Deficiency Type I.

Iranian journal of medical sciences, 51(10):720-726.

BACKGROUND: Leukocyte adhesion deficiency (LAD) is a genetic immunodeficiency that severely impairs the leukocyte adhesion cascade and migration to the sites of infection and inflammation. As a result, the main consequence is recurrent and severe infections with bacteria and fungi, which can lead to death. The most common variant, LAD-I, is due to mutations in the integrin beta 2 (ITGB2) gene responsible for the β2 integrin (CD18) subunit. Corrective strategies based on gene therapy and genome editing are the most promising methods for treating genetic defects.

METHODS: In the present experimental in vitro study conducted at Tarbiat Modares University, Tehran, Iran, in 2024, we designed a single-guide RNA (sgRNA) for the CRISPR/Cas9 system to target exon 6 of ITGB2 and performed validation experiments. We also investigated peptide nanocarriers as a potential strategy for delivering the CRISPR components. The PX458 plasmid encoding Cas9 and the designed sgRNA was delivered into HEK293T cells, followed by genome-editing analysis.

RESULTS: Genome-editing analysis confirmed a measurable level of indel formation at the target locus. Furthermore, the results of MPG nanopeptide production and purification demonstrate the potential of peptide nanocarriers for genome-editing systems.

CONCLUSION: Overall, this work establishes a foundation for subsequent knock-in and gene-correction studies in clinically relevant immune cell models, paving the way for potential LAD-I gene therapy applications.

RevDate: 2026-11-08
CmpDate: 2026-11-08

Piao CL, Zhang Y, ML Cui (2026)

Optimized Genetic Transformation Method Facilitates Gene Functional Analysis and Genome Editing in the Asteraceae Model Plant Senecio vulgaris.

Physiologia plantarum, 178(6):.

Senecio vulgaris belongs to the Asteraceae and serves as an important model for studying ecological adaptation, evolutionary processes, and capitulum development. However, our understanding of the molecular regulatory mechanisms of capitulum development has been hindered by low transformation efficiency and the lack of reliable genome editing tools. Here, we report an optimized Agrobacterium-mediated transformation and genome editing method for S. vulgaris using leaf explants, with selection carried out for 6 weeks. Approximately 88% of kanamycin-resistant shoots exhibited normal morphology, and more than 80% of transformants showed strong GFP expression, which was confirmed by Southern blot. Furthermore, we used this method to successfully silence the SnAPETALA1-6, a MADS-box gene associated with inflorescence development, and to edit the phytoene desaturase gene (SvPDS) in S. vulgaris. Taken together, these improved methods overcome earlier technical barriers, enabling in-depth investigation of the molecular evolutionary processes that underpin flower-head formation in Senecio and other Asteraceae.

RevDate: 2026-11-12
CmpDate: 2026-11-08

Niu W, Qian Y, Wang D, et al (2026)

Reconstruction of PAM-interacting domains to broad PAM compatibility.

Genome biology, 27(1):.

The protospacer adjacent motif (PAM) requirement limits CRISPR-Cas9 targetability. Here, we develop REPAM, an ancestral sequence reconstruction-based strategy that re-engineers PAM-interacting domains to expand PAM recognition. REPAM broadens the PAM specificities of Nme1Cas9 and Nme2Cas9 from N4GATT/N4CC to N4CNH, while additional mutations further extend Nme2Cas9 recognition to N4VHH. Applied to SpaCas9, REPAM expands PAM compatibility from NNGYRA to NNHH, increasing theoretical target coverage by approximately 36-fold. The engineered SpaCas9 achieves up to 76.6% editing efficiency in HEK293T cells, outperforming SpRY. Corresponding base editors efficiently generate protective variants and precise splice-site mutations, highlighting REPAM as a versatile platform for CRISPR engineering.

RevDate: 2026-11-12
CmpDate: 2026-11-08

Mao Y, Yang N, Zhao Y, et al (2026)

CROSS: A cross-species chromosome substitution platform for dissecting chromosome architecture and activity.

Nature communications, 17(1):.

The functional integrity of a mammalian chromosome depends on its long-term co-evolution with species-specific nuclear environment. How chromosomes co-adapt with their native environment to define 3D architecture and transcription remains unclear, largely due to a lack of experimental models that dissect this co-evolution. Here, we report cross-species chromosome substitution (CROSS), a method enabling stable, scarless replacement of host chromosomes with divergent orthologs. We integrate microcell-mediated chromosome transfer with CRISPR/Cas9 to import the intact 152-Mb rat X chromosome into male mouse embryonic stem cells, and subsequently replace the mouse X chromosome, maintaining its stability and integrity. Rat-specific LINE1 and RatSatRep2 repeats recruit mouse SETDB1 inefficiently, causing local H3K9me3 loss. This triggers 3D remodeling, characterized by de novo topologically associating domain (TAD) boundaries that aberrantly activate adjacent genes, including Rhox5, impairing differentiation. We provide a platform for dissecting sequence and epigenome cooperation in chromosome regulation, and evaluating fidelity of large-scale heterologous DNA.

RevDate: 2026-11-10
CmpDate: 2026-11-09

Raudstein M, Datsomor AK, Stewart R, et al (2026)

The potential for large-scale genome editing in finfish aquaculture via germline stem cell culture and transplantation.

Frontiers in genetics, 17:1924271.

Genome editing has emerged as a promising tool to complement selective breeding programmes and accelerate genetic gain in aquaculture. Although CRISPR-based genome editing has been successfully applied in several economically important fish species, its application at an industry-relevant scale remains challenging due to limitations of current delivery methods, which primarily rely on manual embryo microinjection. This approach is labour-intensive, technically demanding, and frequently results in high levels of mosaicism in founder individuals, necessitating additional generations of breeding to establish stable genotypes. In this mini review, we discuss the potential of combining germline stem cell (GSC) culture and transplantation approaches as an alternative platform for further improved genome editing in fish. By enabling genetic changes to be introduced, validated, and expanded in vitro prior to germline transmission, this approach has the potential to improve scalability, reduce mosaicism, and shorten breeding timelines. Although several technical challenges remain, continued progress in GSC culture and transplantation methodologies could facilitate the practical implementation of tailored genome editing for improved genetic gain, fish health, and welfare in aquaculture.

RevDate: 2026-11-09
CmpDate: 2026-11-09

Chen K, Gao T, Yu L, et al (2026)

RPA-assisted three-channel Cas13a-Cas13b-Cas12a fluorescence architecture for three-channel viral nucleic acid detection.

Analytica chimica acta, 1427:346423.

Multiplex nucleic-acid analysis requires orthogonal signal channels capable of resolving multiple targets without substantial cross-interference. Here, an RPA-assisted three-channel CRISPR fluorescence readout was developed by coupling the distinct collateral-cleavage activities of LwaCas13a, PsmCas13b, and LbaCas12a to FAM-, ROX-, and HEX-based reporters, respectively, for detection of Venezuelan equine encephalitis virus (VEEV), tick-borne encephalitis virus (TBEV), and an eastern/western equine encephalitis virus (EEEV/WEEV) group target. The corresponding singleplex assays showed no detectable cross-reactivity with the tested non-target viral templates and achieved operational analytical detection limits of 10 copies/μL for VEEV and TBEV and 100 copies/μL for the EEEV/WEEV group assay. Integration of the three Cas-crRNA-reporter modules into one downstream reaction enabled discrimination of single-, dual-, and three-target combinations, with an analytical detection limit of 100 copies/μL for each target in the equal-concentration three-target mixture. Reporter optimization provided balanced channel responses, while inter-day repeatability and interlaboratory reproducibility yielded coefficients of variation below 10%. In a preliminary matrix evaluation using contrived equine nasal-swab samples, plasmid-spiked samples and unspiked negative controls showed concordant classification between the CRISPR readout and RT-qPCR, indicating compatibility of the assay workflow with the tested sample matrix. The method provides a three-channel analytical architecture that consolidates three downstream CRISPR readouts into one reaction while retaining target-assigned fluorescence interpretation.

RevDate: 2026-11-10
CmpDate: 2026-11-10

Su F, Vipasha V, Dong Y, et al (2026)

Differential Impact of CRISPR/Cas9-Mediated OsMIR396ef Mutagenesis on Yield Components Across Eight Diverse Rice Varieties.

Physiologia plantarum, 178(6):.

Substantial gains in rice productivity are a continual demand for breeders, farmers, as well as consumers. Identifying and introducing favorable yield-related genes in elite cultivars is the most efficient strategy for increasing yield. So far, many yield-related genes in rice have been cloned. However, rice varieties with a vast diversity of genetic constitutions differ tremendously in the levels of grain yield. Here, we edited yield-related MIR396e and MIR396f genes in eight japonica rice varieties and found that mutation efficiency varied with genetic background in the T0 generation. Notably, the knockout of MIR396e and MIR396f genes resulted in increased leaf, panicle, and grain size in all eight genetic backgrounds. However, plant height, culm strength, grain number per panicle, and seed setting rate varied with different genetic backgrounds. Results also showed that among the eight varieties, grain yield increased in five different rice varieties compared to the corresponding wild type, while three of them had decreased yield due to the reduced number of grains per panicle or the seed-setting rate. Thus, our findings broaden the understanding that OsmiR396 can have diverse, even opposing effects on grain yield and plant architecture among genetically distinct rice varieties.

RevDate: 2026-11-12
CmpDate: 2026-11-10

Patel P, Treat AR, Gonzalez R, et al (2026)

Archaeal histones coordinate conserved DNA sequence motifs to promote CRISPR adaptive immunity.

Nucleic acids research, 54(21):.

Archaea and bacteria acquire resistance to viruses by integrating fragments of foreign DNA at the beginning of a CRISPR locus. In the archaeon Pyrococcus furiosus, histones bind the leader to promote specific integration at the first CRISPR repeat. However, it remains unknown whether archaeal CRISPR leaders contain conserved DNA sequence motifs required for integration. Here, we analyze 542 archaeal CRISPR leaders found across Thermococcales and Methanococcales. We identify 36 motifs found up to 500 bps upstream of archaeal CRISPR loci. Scrambling or truncating novel motifs or histone binding sites found 100-400 bps upstream of the P. furiosus CRISPR modestly decreases integration efficiency. However, mutation of motif T2, which overlaps with the proximal histone site and is adjacent to the CRISPR, ablates both histone-mediated and histone-independent integration. Mutations tiled across T2 reveal that a pyrimidine at position -3 of the leader is required for histone-independent integration, and basepairs -4 to -19 are required for histone-mediated integration. T2 is found in most Thermococcales, and a similar sequence is found in most Methanococcales leaders, suggesting this motif may be a broadly conserved element that facilitates CRISPR adaptive immunity across taxonomic orders. These data shed light on the sequence requirements for histone-mediated DNA integration.

RevDate: 2026-11-10
CmpDate: 2026-11-10

Saini A, Sharma N, Sharma N, et al (2026)

CRISPR interference-based gene silencing in insects: from functional genomics to prospective insect-pest management applications.

Molecular biology reports, 53(1):.

Insect-pests remain a major constraint to global agriculture, causing yield losses through direct feeding and transmission of phytopathogens. Chemical pesticides and transgenic crops expressing Bacillus thuringiensis toxins have shown initial success; however, their use is increasingly constrained by resistance, non-target effects, environmental contamination and regulatory restrictions. Although RNA interference (RNAi) presents a targeted and eco-friendly alternative, it is limited by species variability, rapid double-stranded RNA (dsRNA) degradation, inconsistent silencing and off-target effects. Nuclease-active Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9 (CRISPR/Cas9) enables genetic editing, but its irreversible genome modifications raise ethical, ecological and regulatory concerns. CRISPR interference (CRISPRi) offers a programmable approach for sequence-specific, reversible transcriptional suppression without inducing double-strand DNA breaks. Using catalytically inactive Cas9 (dead Cas9 or dCas9) -guided by single-guide RNA (sgRNA), CRISPRi inhibits transcription initiation or elongation while maintaining genomic integrity. Experimental studies in insect models, including disease-vector mosquitoes, have demonstrated effective suppression of coding and non-coding genes, supporting CRISPRi as a functional genomics tool. This review discusses CRISPRi mechanisms, applications, advantages and limitations in insects, comparing it with RNAi and CRISPR/Cas9. Overall, current evidences indicate that CRISPRi is a precise and non-mutagenic platform for insect-pest management, particularly where controlled, reversible and species-specific gene regulation is desirable. However, its application in agricultural pest management remains an extrapolation from functional-genomics studies and requires validation in pest species under whole-organism and field-relevant conditions.

RevDate: 2026-11-12
CmpDate: 2026-11-10

Sheet S, Kim HJ, Kim WI, et al (2026)

CRISPR/Cas9-mediated PD-L1 knockout reshapes temporal transcriptomic responses to PRRSV infection in porcine alveolar macrophages.

PloS one, 21(11):e0355142.

Porcine reproductive and respiratory syndrome virus (PRRSV) suppresses innate antiviral immunity in porcine alveolar macrophages, and the PD-1/PD-L1 axis is thought to contribute to this immune dysregulation. This study investigated how PD-L1 knockout (KO) alters the host transcriptional response to PRRSV infection compared to wild-type (WT) immortalized porcine alveolar macrophages (iPAMs). PD-L1 KO iPAMs were generated by CRISPR/Cas9 targeting exon 2 of porcine CD274 locus, and knockout was confirmed in clone #35. After PRRSV-2 infection, KO#35 cells exhibited approximately 5-fold reduced viral RNA accumulation at 48 h post-infection compared with WT cells. Time-course RNA sequencing at 0, 6, and 48 h post-infection was then performed to characterize the transcriptional consequences of PD-L1 KO during acute PRRSV-2 infection. PD-L1 KO iPAMs exhibited downregulation of immune checkpoint and exhaustion-related genes (LAG3, PDCD1, TIGIT, TOX family) and NF-κB inhibitors (SOCS4, NFKBIA), alongside upregulation of antigen presentation (MHC I/II genes like SLA-2, SLA-5, B2M, SLA-DMA, SLA-DMB, HLA-DRA) and co-stimulatory molecules (CD80, CD86, CD40). Cytokine profiling indicated a reprogrammed response favoring antiviral signaling, including sustained elevation of CXCL10/11, ISGs (MX1/2, ISG15, IFIT1-3), and select interleukins (IL15, IL6), while suppressing pro-inflammatory TNF and CXCL8 across time points. Pathway enrichment analysis revealed significant enrichment of the cytokine-receptor interaction pathway. Weighted gene co-expression network analysis (WGCNA) further identified a key co-expression module containing 1,763 DEGs that was associated with innate immune activation. Moreover, protein-protein interaction (PPI) network analysis detected PXDN as a key hub gene connected to the PI3K-Akt signaling and natural killer cytotoxicity pathways. These findings provide transcriptomic insight into the association between PD-L1 deficiency and altered macrophage transcriptional responses to PRRSV infection in an in-vitro iPAM model and provide a basis for future mechanistic investigation of PD-L1 in PRRSV pathogenesis.

RevDate: 2026-11-12
CmpDate: 2026-11-11

Li K, Tang W, Shi B, et al (2026)

Visual and rapid detection of Fasciola spp. in fecal samples using a one-pot RPA-CRISPR/Cas12a assay.

BMC veterinary research, 22(1):.

BACKGROUND: Fasciolosis caused by Fasciola spp. has substantial veterinary and public-health importance, while conventional fecal microscopy has limited sensitivity and PCR depends on laboratory equipment. This study aimed to develop a rapid, visual one-pot recombinase polymerase amplification (RPA)-CRISPR/Cas12a assay for detecting Fasciola DNA in fecal samples.

RESULTS: RPA primers and CRISPR RNAs targeting the conserved internal transcribed spacer 1 region were screened and optimized. The final assay was completed at 37 °C within 30 min, and results were read using a fluorescence detector or visualized under blue light. The analytical limit of detection was 10 copies/µL, and DNA corresponding to 0.1 egg equivalents was detectable. No cross-reactivity was observed with six non-target parasite species. Among 54 field fecal samples (42 yak and 12 Tibetan sheep samples) from Xizang, three were positive, with complete qualitative agreement between the one-pot assay and conventional PCR in this limited sample set. In a preliminary mixed-DNA interference evaluation using 24 artificially spiked fecal samples, all 23 samples containing Fasciola DNA, including samples containing DNA from both Fasciola species or Fasciola DNA combined with selected non-target parasite DNA, were positive, whereas the non-target-only control was negative.

CONCLUSIONS: The one-pot RPA-CRISPR/Cas12a assay provides rapid and analytically sensitive detection of Fasciola DNA, with no cross-reactivity observed within the tested parasite panel. The method shows potential for surveillance and resource-limited testing, but broader multi-region validation and simplified sample preparation are required before routine field or point-of-care deployment.

RevDate: 2026-11-12
CmpDate: 2026-11-11

Ma Y, Li J, Jin X, et al (2026)

A quantitative and visual detection probe based on isothermal nucleic acid amplification coupled with CRISPR/Cas12a system (INACS) for miR155 detection.

Journal of nanobiotechnology, 24(1):.

MicroRNAs (miRNAs) have emerged as ideal biomarkers for early clinical diagnosis. Achieving the accurate detection of miRNAs plays a critical role for assuring its implementation in their clinical applications. In this study, we developed a dual-signal amplified ultrasensitive fluorescent sensing platform for miR155 detection by coupling isothermal nucleic acid amplification with the CRISPR/Cas12a system (INACS). Using a hairpin nucleic acid probe (HP) as the substrate, the system specifically recognizes the target miR155, triggering the opening of the hairpin loop structure. Subsequently, under the catalysis of Bst DNA polymerase, target gene amplification produces dsDNA with a specific sequence. This dsDNA activates the trans-cleavage activity of Cas12a, which cleaves reporter strands labeled with quencher and fluorescent groups, restoring the fluorescence signal. The fluorescence intensity is proportional to miR155 concentration, exhibiting a strong linear relationship between fluorescence intensity ratio and the logarithm of miR155 concentration over the range of 0.5-50 pM (r = 0.9961). By integrating nucleic acid amplification with CRISPR/Cas12a amplification, INACS achieves high sensitivity, excellent selectivity, and a detection limit as low as 34.46 fM. INACS was successfully applied to human serum samples, revealing elevated miR155 levels in breast cancer patients compared to non-cancer controls. Moreover, INACS was adapted for semi-quantitative detection using lateral flow assay (LFA) test strips. Results were assessed by naked-eye color comparison, facilitating rapid onsite auxiliary diagnosis of breast cancer. The LFA outcomes were consistent with serum fluorescence measurements, enabling efficient and user-friendly visual detection. This work thus provides a promising tool for early clinical diagnosis.

RevDate: 2026-11-11
CmpDate: 2026-11-11

Chen Q, Chen Z, Peng Y, et al (2026)

PAM-Free Programmable Enzymatic Cascade Design Enabling Highly Sensitive CRISPR/Cas12a Lateral Flow Assay for Foodborne Pathogen Detection.

Analytical chemistry, 98(44):30560-30570.

CRISPR/Cas12a-assisted nucleic acid assays have shown great potential for rapid pathogen detection. However, their implementation in lateral flow assays remains constrained by strict protospacer adjacent motif (PAM) requirements and low-contrast, signal-off readouts. To effectively address these limitations, we present a new PAM-free programmable enzymatic cascade-enabled CRISPR/Cas12a lateral flow assay (PAEC-LFA) for highly sensitive foodborne pathogen detection. In this strategy, target amplification products are enzymatically digested to generate programmable single-stranded DNA activators, enabling PAM-independent Cas12a activation and flexible target recognition. Upon activation, Cas12a exhibits efficient trans-cleavage activity, which subsequently triggers terminal deoxynucleotidyl transferase (TdT)-mediated extension, forming an enzymatic cascade that amplifies signal output and generates a high-contrast signal-on readout on lateral flow assays. Integrating RPA and enzymatic digestion with PAM-free Cas12a-TdT signal amplification into two sequential one-pot modules simplifies the workflow, minimizes contamination risk, and maintains effective amplification performance. Under optimized conditions, PAEC-LFA achieved detection limits of 1.05 CFU/mL for Salmonella and Staphylococcus aureus, and 3.13 CFU/mL for Pseudomonas aeruginosa. Visual detection limits in spiked food samples reached 10 CFU/mL for all three pathogens. This work establishes a generalizable PAM-free enzymatic cascade framework for highly sensitive CRISPR/Cas12a lateral flow assays, advancing practical pathogen detection in food safety applications.

RevDate: 2026-11-11
CmpDate: 2026-11-11

Liu G, Meng Z, Zheng W, et al (2025)

Dual-modal aptamer/CRISPR-Cas12a biosensor with Fe-C-N@Au nanozyme for simultaneous detection of azithromycin and macrolide resistance genes and degradation of azithromycin.

Journal of hazardous materials, 498:139850.

The pervasive contamination of aquatic systems by azithromycin (AZM) and its role in proliferating macrolide resistance genes, particularly ermB, constitutes a critical threat to ecological and public health. Current methodologies lack integrated on-site detection and efficient degradation. We engineered a multifunctional single-atom iron nanozyme decorated with gold nanoparticles (Fe-C-N@Au) platform integrating aptamer-mediated recognition, CRISPR-Cas12a detection, colorimetric-photothermal dual-modal sensing, and nanozyme catalysis. For detection, AZM binding liberates Fe-C-N@Au-aptamer conjugates from magnetic complexes, enabling quantification through nanozyme-catalyzed 3,3',5,5'-tetramethylbenzidine (TMB) oxidation and oxTMB-derived photothermal signals under near-infrared radiation (NIR) irradiation. Parallel ermB identification occurs via Cas12a trans-cleavage-triggered Fe-C-N@Au release. This approach achieves exceptional sensitivity with limit of detection (LOD) of 2.34 pM (colorimetric) and 9.17 pM (photothermal) for AZM, alongside 3.77 pM (colorimetric) and 8.46 pM (photothermal) for ermB. Synchronous quantification is facilitated through smartphone colorimetry and portable infrared thermometry. Crucially, the identical Fe-C-N@Au nanozyme efficiently activates hydrogen peroxide (H2O2) to generate reactive oxygen species (ROS), accomplishing > 90 % AZM degradation within 60 min. The integrated "detect-and-degrade" system creates a closed-loop process that couples real-time monitoring with immediate remediation. This field-deployable strategy combats antibiotic resistance by simultaneously eliminating selective pressure and genetic determinants, providing a transformative approach for controlling the dissemination of antimicrobial resistance at the source.

RevDate: 2026-11-10
CmpDate: 2026-11-10

Liu M, Huang K, Zhang J, et al (2026)

CRISPR live-cell imaging reveals chromatin dynamics and enhancer interactions at multiple non-repetitive loci.

Nature biotechnology, 44(11):1906-1919.

Existing methods to visualize dynamic changes in the three-dimensional genome, promoter-enhancer interactions and the influence of epigenetic modifications in non-repetitive loci are limited. Here we introduce CRISPR PRO-LiveFISH (Pooled gRNAs with Orthogonal bases LiveFISH), which combines orthogonal bases from expanded genetic alphabet technology and rational single guide RNA (sgRNA) design to efficiently label multiple non-repetitive loci in living cells. The optimized method allows simultaneous imaging of up to six genomic loci and uses as few as 10 sgRNAs for non-repetitive loci imaging without signal amplification. We demonstrate the method in diverse cell types, including primary cells, and apply it to reveal enhancer-promoter dynamics and a correlation between genomic dynamics and epigenetic states. We also show that PCDHα-enhancer interactions may persist despite spatial mobility and that BRD4 maintains super-enhancer contacts regulating MYC oncogene expression in cancer cells. CRISPR PRO-LiveFISH can be applied to diverse studies of chromatin dynamics and genome organization in living cells.

RevDate: 2026-11-10
CmpDate: 2026-11-10

McDiarmid TA, Taylor ML, Chen W, et al (2026)

A parts list of promoters and gRNA scaffolds for mammalian genome engineering and molecular recording.

Nature biotechnology, 44(11):1894-1905.

A standardized 'parts list' of sequences for genetic engineering of microbes has been indispensable to progress in synthetic biology, but few analogous parts exist for mammalian systems. Here we design libraries of extant, ancestral, mutagenized or miniaturized variants of polymerase III promoters and guide RNA (gRNA) scaffolds and quantify their abilities to mediate precise edits to the mammalian genome through multiplex prime editing. We identify thousands of parts for reproducible editing in human and mouse cell lines, including hundreds with greater activity than commonly used sequences. Saturation mutagenesis screens identify tolerated sequence variants that further enhance sequence diversity. In an application to molecular recording, we design a 'ten key' array that, in mammalian cells, achieves balanced activity of pegRNAs as predicted by the activity of the component parts. The data reported here will aid the design of synthetic loci encoding arrays of gRNAs exhibiting predictable, differentiated levels of activity for applications in multiplexed perturbation, biological recorders and complex genetic circuits.

RevDate: 2026-11-05
CmpDate: 2026-11-04

Syombua ED, Venado RE, Achary VMM, et al (2026)

Genome editing for nutritional biofortification in maize: bridging molecular innovation and food security in the Global South.

Frontiers in plant science, 17:1868062.

Micronutrient deficiency is a prevalent challenge in Sub-Saharan Africa and other geographies of the Global South where populations rely on maize as the primary calorie source. Globally, the most widespread micronutrient deficiencies include iron, zinc, and vitamin A, which are inherently low in maize. Besides, maize grain protein percentage of the essential amino acids falls below the recommended daily allowance. Traditional plant breeding practices have enabled the generation of hybrid plant varieties with superior nutritional value, such as Quality Protein Maize (QPM). However, obtaining novel varieties from existing gene pools often results in linkage drag drawbacks, yield penalties, poor-quality kernels, and requires multiple backcrossing cycles. Thus, genome editing offers a precise strategy for enhancing nutritional value, without the associated trade-offs. CRISPR/Cas, base editors and prime editors reduce breeding timelines and enable precise targeting of nutrient-accumulation pathways. In this review, we explore how genome editing technology could serve as the next-generation approach for maize biofortification. The review outlines various ways CRISPR/Cas allow precise and targeted modification of genes responsible for micronutrient biosynthesis, transport, and storage. We describe the application of CRISPR in disrupting negative regulators of nutrient transport, up-regulating nutrient biosynthesis pathways, and knocking out anti-nutritional factor genes. We further highlight that CRISPR-enabled biofortification is not just a technological innovation but a public health intervention for mitigating nutrient deficiencies. However, fully unlocking the potential of gene-edited biofortified maize will require coordinated efforts in regulatory policy and alignment with farmer/consumer preference.

RevDate: 2026-11-05
CmpDate: 2026-11-04

Fang Q, Lin Y, Hu G, et al (2026)

Point-of-care testing in the diagnosis of infectious diseases.

Frontiers in microbiology, 17:1949318.

Point-of-care testing (POCT) has emerged as an indispensable diagnostic strategy for addressing the increasing global burden of infectious diseases and the worsening threat of antimicrobial resistance. Owing to prominent advantages such as rapid detection of infectious agents, portability, and ease of accessibility, POCT can effectively address the inherent limitations of traditional laboratory diagnostic workflows. This review summarizes the core technical platforms that underlie current POCT technologies, including lateral flow assays, chemiluminescence immunoassays, isothermal amplification systems, CRISPR/Cas-based diagnostic systems, and microfluidic chip technologies. Furthermore, we describe the key clinical scenarios in which POCT can be applied, including respiratory tract, bloodstream, gastrointestinal, urinary tract, and sexually transmitted infections. We also comprehensively discuss the technical characteristics and clinical applicability of mainstream POCT modalities, including immunochromatography and molecular diagnostics. Despite limitations associated with detection sensitivity, quality control, cost efficiency, and clinical integration, POCT technology continues to undergo consistent improvements. Advances in nanomaterials, microfluidic engineering, and artificial intelligence and continuous improvements in industry standardization have led to increased performance, systematic integration, and intelligent detection in POCT. Given these technological advancements and optimizations, POCT shows promising applicability and is therefore expected to become a core diagnostic tool for both precision clinical management and epidemic prevention and control in public health.

RevDate: 2026-11-05
CmpDate: 2026-11-04

Dionisio G, Tiwari S, P Jogam (2026)

Editorial: CRISPR/CAS innovations: advancing precision and specificity in plant genetic engineering.

Frontiers in plant science, 17:2012559.

RevDate: 2026-11-04

Mogila I, Smalakyte D, G Tamulaitis (2026)

Expanding arsenal of type III CRISPR-Cas antiviral defense.

FEMS microbiology reviews pii:9011809 [Epub ahead of print].

CRISPR-Cas systems are adaptive immune systems that protect prokaryotes from invading genetic elements through acquisition of foreign nucleic acid sequences and RNA-guided recognition of target molecules. Among the diverse CRISPR-Cas families, type III systems represent a highly complex and versatile branch that couples sequence-specific interference with nucleotide-based signaling and activation of diverse downstream immune responses. Recent discoveries have substantially expanded the functional diversity of type III CRISPR-Cas systems, revealing new subtypes, ancillary effectors, nucleotide second messengers, signal-degrading enzymes, and viral counter-defense strategies. Here, we summarize current mechanistic and structural insights into type III CRISPR-Cas biology, from adaptation and target recognition to immune signaling, ancillary effector-mediated responses, and defense regulation. We further discuss emerging biotechnological applications of type III systems and highlight key unanswered questions shaping future research in this rapidly evolving field.

RevDate: 2026-11-08
CmpDate: 2026-11-04

Borah M, Gautron N, Courdavault V, et al (2026)

FASTOP─Fast Editing Toolkit for Top Expression Sites in Yeast.

Journal of agricultural and food chemistry, 74(43):34106-34115.

Budding yeast Saccharomyces cerevisiae is a widely used chassis for producing food- and agriculture-related compounds, but construction of multienzyme pathways often requires repeated genomic integration. We developed FASTOP, a genome-editing toolkit for rapid engineering of eight transcriptionally active genomic hot-spot loci. FASTOP combines selectable markers, extended homology arms, and Cas9/gRNA-assisted integration, and enables PCR-free release of donor cassettes by restriction digestion to reduce sequence errors introduced during amplification. After characterizing the sites, we integrated a five-gene naringenin biosynthetic pathway into the hot spots as a proof of concept. Our results demonstrated that, upon expressing the five essential genes in simple shake-flask culture, naringenin production reached 505.7 mg/L, 6-fold higher than an episomal control expressing the same pathway genes and 4.5-fold higher than the previously reported strain using additional precursor engineering and controlled bioreactor cultivation. FASTOP therefore provides a practical platform for the rapid assembly of multienzyme pathways in yeast for stable heterologous gene expression.

RevDate: 2026-11-06

Ghoreyshizadeh E, Namaki M, Naeimi F, et al (2026)

The plasmid arsenal within: Type IV-A CRISPR-Cas systems in Enterobacteriaceae as modulators of resistance and virulence.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 146:106053 pii:S1567-1348(26)00177-2 [Epub ahead of print].

The Enterobacteriaceae family, which includes prominent pathogens such as K. pneumoniae, E. coli, and S. enterica, poses a significant global health threat due to the rapid dissemination of multidrug resistance and virulence determinants. Central to this dissemination are conjugative plasmids, which act as vehicles for horizontal gene transfer. Among the myriad defense systems that interact with these mobile genetic elements, the type IV-A CRISPR-Cas system stands out due to its enigmatic nature and unique plasmid-centric biology. Unlike canonical CRISPR-Cas systems that are chromosomal and target bacteriophages, type IV-A systems are predominantly encoded on large, conjugative plasmids, particularly those bearing IncHI1B/IncFIB replicons. This review synthesizes current evidence on the biology of type IV-A systems within Enterobacteriaceae, elucidating their role as mediators of inter-plasmid competition, their paradoxical association with the spread of antibiotic resistance and virulence genes, and their emerging applications as programmable tools. We explore the mechanistic basis for their function as a natural CRISPR interference (CRISPRi) system, the epidemiological landscape of their distribution, and the dual role they play in both constraining and facilitating the dissemination of clinically relevant traits. Finally, we propose ambitious research avenues, including the development of "plasmid-destroying" probiotics, the use of type IV-A systems as epidemiological biosensors, and the exploration of hypotheses concerning their role in mediating bacterial "altruism" or serving as a "genetic memory" of the plasmid "secretoome."

RevDate: 2026-11-04

He Z, Zhang J, Kuang S, et al (2026)

Ecological and Molecular Basis of Capripoxvirus Cross-Host Transmission: From Transmission Networks to Adaptive Evolution.

Veterinary dermatology [Epub ahead of print].

BACKGROUND: Capripoxvirus (CaPV), comprising sheeppox virus (SPPV), goatpox virus (GTPV) and lumpy skin disease virus (LSDV), represents a growing transboundary threat to global livestock, with expanding geographic distribution and increasingly prominent cross-species transmission in mixed farming systems.

OBJECTIVES: This review systematically examines the multifaceted drivers of CaPV spillover from ecological, molecular and evolutionary perspectives.

METHODS: This review integrates ecological, molecular and evolutionary analyses, incorporating mathematical modelling and summarising advances in CRISPR/Cas-based diagnostics.

RESULTS: Ecologically, a tripartite network involving habitat sharing, landscape permeability (e.g., forest farmland edges) and arthropod vectors is proposed; mathematical modelling identifies vector-to-host ratio and vaccination coverage as critical modulators of outbreak severity. Molecularly, genetic plasticity in terminal genomic regions (e.g., ankyrin family) and host range genes (HRGs) such as M062R, M159, and LSDV012 enable antagonism of host restriction factors including SAMD9, IFIT1 and PKR, with the C7L superfamily playing a pivotal role in breaching species barriers. Evolutionarily, recombination-driven diversification, immune selection pressure and genetic bottlenecks collectively shape adaptive radiation and frequent host jumping events. Advances in CRISPR/Cas-based diagnostics are summarised. However, live attenuated vaccines show limitations in safety and efficacy.

Persistent challenges include ecological surveillance, molecular discrimination of the three species and vaccine-wild type recombination risks. By integrating these disciplines, this review offers a comprehensive framework for understanding CaPV cross-species transmission and supports the design of precision control strategies targeting ecological and molecular vulnerabilities.

RevDate: 2026-11-06
CmpDate: 2026-11-05

Matvere A, Menchon G, Martinetti L, et al (2026)

CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability.

Molecular cancer, 25(1):.

Resistance to therapy remains a critical challenge in cancer. This is exemplified by TGF-β pathway inhibitors which, despite broad clinical testing, have failed to deliver survival benefit. More precise SMAD3 targeting has shown preclinical promise, yet resistance mechanisms to SMAD3 inhibition remain entirely unknown. Using complementary genome-wide CRISPR activation and knockout screens, we discover that cancer cells escape SMAD3 inhibition through metabolic reprogramming. Strikingly, this escape is driven not by transcriptional bypass but by the lactate transporter MCT1, with the effect preserved across BRAF-mutated melanoma, KRAS-mutated lung adenocarcinoma, and mouse melanoma. Mechanistically, SMAD3 inhibition creates energetic stress that cancer cells exploit through MCT1. By conferring metabolic flexibility and switching toward glycolysis under drug pressure, MCT1 increases anabolic activity to drive lipid and cholesterol synthesis. Pharmacological and genetic MCT1 inhibition synergizes strongly with SMAD3 blockade to impair tumor viability in BRAF-mutated melanoma, while suppressing drug-tolerant cell emergence in BRAF inhibitor-resistant cells. Critically, this synergy extends to preclinical models, where co-inhibition of SMAD3 and MCT1 potently reduces tumor growth in vivo. Given the additional and well-established role of MCT1 in shaping the tumor immune microenvironment via lactate transport, these results position MCT1 as both a metabolic and immunological target and provide a strong rationale for the repurposing of TGF-β/SMAD3 pathway inhibitors in combination.

RevDate: 2026-11-06
CmpDate: 2026-11-05

Liu H, Zhang Y, Wen H, et al (2026)

RPA-CRISPR/Cas12-based rapid visual on-site detection method for bovine Cryptosporidium.

BMC veterinary research, 22(1):.

BACKGROUND: Four types of Cryptosporidium (C. parvum, C. bovis, C. ryanae, and C. andersoni) and mixed infections were common among cattle in the Inner Mongolia Autonomous Region of China, causing severe harm. For grassroots farms and pastures, the prevention and control of bovine Cryptosporidium requires simultaneous detection of the four major Cryptosporidium species, and a one-time diagnosis of bovine Cryptosporidium without distinguishing between species is necessary to achieve more efficient prevention and treatment. In this study, recombinant polymerase amplification (RPA) was combined with the CRISPR/Cas system to design crRNAs and screen RPA primers targeting the 18S rRNA genes of four bovine Cryptosporidium species that primarily infect cattle.

RESULTS: Detection results were presented using two distinct single-stranded DNA reporter molecules via fluorescence quantification and lateral flow immunochromatography assay (LFIA) test strips. Using specificity and sensitivity assessments on clinical samples, the RPA-CRISPR/Cas12 visual on-site rapid detection method for bovine Cryptosporidium established in this study was completed within 60 min, with a minimum detection limit of 0.1 copies/µL. There was no cross-reactivity with the six pathogens: Haemonchus contortus, coccidia, Cysticercus tenuicollis, trematode, Caenorhabditis elegans, and tapeworm. Four types of bovine Cryptosporidium were specifically detected.

CONCLUSION: Clinical detection showed an 86% positivity rate for bovine Cryptosporidium, consistent with the Cryptosporidium nested PCR method (National Standard). Therefore, the RPA-CRISPR/Cas12a rapid on-site detection method established in this study has high specificity and sensitivity, convenience, and speed, without requiring specialized operational steps or expensive equipment.

RevDate: 2026-11-06
CmpDate: 2026-11-05

Malitha MD, Jain H, Wolobah Z, et al (2026)

CRISPR-integrated nanobiosensors for rapid and ultra-sensitive food allergen detection: a comprehensive review.

Food science and biotechnology, 35(13):3521-3538.

UNLABELLED: Reliable allergen detection in increasingly complex and globally distributed food systems demands analytical platforms that overcome the limitations of ELISA, PCR, and traditional biosensors. CRISPR-based diagnostics provide exceptional specificity and programmability, yet their practical performance depends heavily on signal amplification efficiency, enzyme stability, and tolerance to inhibitors commonly present in processed food matrices. Integrating nanomaterials with CRISPR systems offers powerful enhancements in sensitivity, kinetics, and matrix robustness, but a unified evaluation of this convergence is still lacking. This review critically examines CRISPR-nanotechnology-enabled allergen detection by integrating insights on biomarker selection, Cas enzyme architectures, nanomaterial-mediated signal engineering, and emerging device formats including microfluidics, lateral flow assays, and smartphone-based platforms. Persistent challenges such as quantification, multiplexing, reagent stability, and regulatory validation are highlighted. By mapping these technological dependencies and bottlenecks, this review provides a clear roadmap for advancing CRISPR-integrated nanobiosensors toward rapid, ultra-sensitive, and field-deployable allergen monitoring solutions.

SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at https://doi.org/10.1007/s10068-026-02206-9.

▼ ▼ LOAD NEXT 100 CITATIONS

ESP Quick Facts

ESP Origins

In the early 1990's, Robert Robbins was a faculty member at Johns Hopkins, where he directed the informatics core of GDB — the human gene-mapping database of the international human genome project. To share papers with colleagues around the world, he set up a small paper-sharing section on his personal web page. This small project evolved into The Electronic Scholarly Publishing Project.

ESP Support

In 1995, Robbins became the VP/IT of the Fred Hutchinson Cancer Research Center in Seattle, WA. Soon after arriving in Seattle, Robbins secured funding, through the ELSI component of the US Human Genome Project, to create the original ESP.ORG web site, with the formal goal of providing free, world-wide access to the literature of classical genetics.

ESP Rationale

Although the methods of molecular biology can seem almost magical to the uninitiated, the original techniques of classical genetics are readily appreciated by one and all: cross individuals that differ in some inherited trait, collect all of the progeny, score their attributes, and propose mechanisms to explain the patterns of inheritance observed.

ESP Goal

In reading the early works of classical genetics, one is drawn, almost inexorably, into ever more complex models, until molecular explanations begin to seem both necessary and natural. At that point, the tools for understanding genome research are at hand. Assisting readers reach this point was the original goal of The Electronic Scholarly Publishing Project.

ESP Usage

Usage of the site grew rapidly and has remained high. Faculty began to use the site for their assigned readings. Other on-line publishers, ranging from The New York Times to Nature referenced ESP materials in their own publications. Nobel laureates (e.g., Joshua Lederberg) regularly used the site and even wrote to suggest changes and improvements.

ESP Content

When the site began, no journals were making their early content available in digital format. As a result, ESP was obliged to digitize classic literature before it could be made available. For many important papers — such as Mendel's original paper or the first genetic map — ESP had to produce entirely new typeset versions of the works, if they were to be available in a high-quality format.

ESP Help

Early support from the DOE component of the Human Genome Project was critically important for getting the ESP project on a firm foundation. Since that funding ended (nearly 20 years ago), the project has been operated as a purely volunteer effort. Anyone wishing to assist in these efforts should send an email to Robbins.

ESP Plans

With the development of methods for adding typeset side notes to PDF files, the ESP project now plans to add annotated versions of some classical papers to its holdings. We also plan to add new reference and pedagogical material. We have already started providing regularly updated, comprehensive bibliographies to the ESP.ORG site.

SUPPORT ESP: Click Covers to Order from Amazon
The ESP project will earn a commission.

CRISPR-Cas

By delivering the Cas9 nuclease, complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be precisely cut at any desired location, allowing existing genes to be removed and/or new ones added. That is, the CRISPR-Cas system provides a tool for the cut-and-paste editing of genomes. Welcome to the brave new world of genome editing. R. Robbins

Electronic Scholarly Publishing
961 Red Tail Lane
Bellingham, WA 98226

E-mail: RJR8222 @ gmail.com

Papers in Classical Genetics

The ESP began as an effort to share a handful of key papers from the early days of classical genetics. Now the collection has grown to include hundreds of papers, in full-text format.

Digital Books

Along with papers on classical genetics, ESP offers a collection of full-text digital books, including many works by Darwin and even a collection of poetry — Chicago Poems by Carl Sandburg.

Timelines

ESP now offers a large collection of user-selected side-by-side timelines (e.g., all science vs. all other categories, or arts and culture vs. world history), designed to provide a comparative context for appreciating world events.

Biographies

Biographical information about many key scientists (e.g., Walter Sutton).

Selected Bibliographies

Bibliographies on several topics of potential interest to the ESP community are automatically maintained and generated on the ESP site.

ESP Picks from Around the Web (updated 28 JUL 2024 )